KR20120052034A - Spiro compound and organic light emitting device including the same - Google Patents

Spiro compound and organic light emitting device including the same Download PDF

Info

Publication number
KR20120052034A
KR20120052034A KR1020100113475A KR20100113475A KR20120052034A KR 20120052034 A KR20120052034 A KR 20120052034A KR 1020100113475 A KR1020100113475 A KR 1020100113475A KR 20100113475 A KR20100113475 A KR 20100113475A KR 20120052034 A KR20120052034 A KR 20120052034A
Authority
KR
South Korea
Prior art keywords
light emitting
group
compound
organic light
emitting device
Prior art date
Application number
KR1020100113475A
Other languages
Korean (ko)
Other versions
KR101171232B1 (en
Inventor
이준엽
조용주
Original Assignee
단국대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 단국대학교 산학협력단 filed Critical 단국대학교 산학협력단
Priority to KR1020100113475A priority Critical patent/KR101171232B1/en
Publication of KR20120052034A publication Critical patent/KR20120052034A/en
Application granted granted Critical
Publication of KR101171232B1 publication Critical patent/KR101171232B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/54Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings
    • C07C13/547Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings at least one ring not being six-membered, the other rings being at the most six-membered
    • C07C13/567Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings at least one ring not being six-membered, the other rings being at the most six-membered with a fluorene or hydrogenated fluorene ring system
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

PURPOSE: A spiro compound is provided to have excellent quantum efficiency together with excellent thermal stability and membrane stability, in case of using for a hole transport material of an organic electroluminescent device, a dopant material of a light-emitting layer, a host material of a light-emitting layer, an electron transport material, a host of fluorescent material, a fluorescent device and a phosphorescent device. CONSTITUTION: A spiro compound is in chemical formula 1. In chemical formula 1, R^1-R^6 are same or different, and can't be hydrogen altogether, at least one of R^1-R^6 is one of functional groups in chemical formula 1-a, 1-b, 1-c, and a-d, and residue of R^1-R^6 is respectively a C1-9 alkyl group, a C6-30 aryl group, or a C5-30 heteroaryl, or at least one of R^1-R^6 is able to form a carbon-conjugated aromatic cycle or a heteroaromatic cycle by combining with carbon in adjacent benzene ring. R^7-R^9 is respectively hydrogen or a C1-9 alkyl group.

Description

스파이로 화합물 및 이를 포함하는 유기전계 발광소자 {Spiro Compound and Organic Light Emitting Device Including the Same}Spiro Compound and Organic Light Emitting Device Including the Same

본 발명은 스파이로 화합물에 관한 것으로서, 보다 상세하게는 열적 안정성, 막안정성 및 양자효율이 우수한 스파이로 화합물 및 이를 포함하는 유기전계 발광소자에 관한 발명이다.The present invention relates to a spiro compound, and more particularly, to a spiro compound having excellent thermal stability, film stability and quantum efficiency, and an organic electroluminescent device comprising the same.

유기전계 발광소자는 기존 액정 표시 장치(LCD), 플라즈마 디스플레이 패널(PDP) 그리고 전계 방출 디스플레이 (FED)등의 타 평판 표시 소자에 비해 구조가 간단하고, 제조 공정상 다양한 장점이 있으며 높은 휘도 및 시야각 특성이 우수하며, 응답속도가 빠르고 구동전압이 낮아 벽걸이 TV등의 평판 디스플레이 또는 디스플레이의 배면광, 조명, 광고판 등의 광원으로서 사용되도록 활발하게 개발이 진행되고 있다.The organic light emitting device has a simpler structure, has various advantages in manufacturing process, and has high luminance and viewing angle compared to other flat panel display devices such as a liquid crystal display (LCD), a plasma display panel (PDP), and a field emission display (FED). Due to its excellent characteristics, fast response speed and low driving voltage, development is being actively conducted to be used as a light source for a flat panel display such as a wall-mounted TV or a back light of a display, an illumination, a billboard.

유기전계 발광소자는 일반적으로 직류 전압을 인가하였을 때 양극으로부터 주입된 정공과 음극으로부터 주입된 전자가 재결합하여 전자-정공 쌍인 엑시톤을 형성하며 이 엑시톤이 안정한 바닥 상태로 돌아오면서 그에 해당하는 에너지를 발광 재료에 전달함에 의해 빛으로 변환된다. In general, an organic light emitting diode recombines holes injected from an anode and electrons injected from a cathode when a DC voltage is applied to form an exciton, an electron-hole pair, and the excitons return to a stable ground state to emit corresponding energy. It is converted to light by transmitting it to the material.

유기전계 발광소자의 효율과 안정성을 높이기 위해 이스트만 코닥사의 탕(C. W. Tang) 등에 의해 두 개의 반대 전극 사이에 적층형 유기물 박막을 구성하여 저전압 구동 유기전계 발광소자가 보고(C. W. Tang, S. A. Vanslyke, Applied Physics Letters, 51권 913페이지, 1987년)된 이래, 다층 박막 구조형 유기전계 발광소자용 유기 재료에 대한 연구가 활발히 진행되고 있다. 이러한 적층형 유기전계 발광소자의 수명은 박막 및 재료의 열적 안정성과 관련이 깊다. 예컨대, 재료의 열안정성이 떨어질 경우 고온 또는 구동온도에서 재료의 결정화가 이루어져 소자의 수명을 단축시키는 원인이 되고 있다. In order to increase the efficiency and stability of organic light emitting devices, a low-voltage driving organic light emitting device is reported by forming a stacked organic thin film between two opposite electrodes by CW Tang of Eastman Kodak Corporation (CW Tang, SA Vanslyke, Applied Physics). Letters, Vol. 51, p. 913, 1987), studies on organic materials for multilayer thin film structured organic light emitting diodes have been actively conducted. The lifetime of the stacked organic light emitting diode is deeply related to the thermal stability of the thin film and the material. For example, when the thermal stability of the material is inferior, crystallization of the material occurs at a high temperature or a driving temperature, which causes a shortening of the life of the device.

유기전계 발광소자에 사용될 수 있는 기존의 스파이로계 화합물 구조로서 스파이로바이플루오렌(spirobifluorene)이 보고되고 있으나 상기 스파이로바이플루오렌화합물은 열적 안정성이 낮은 문제점이 있다.Although spirobifluorene has been reported as a conventional spiro-based compound structure that can be used in an organic light emitting device, the spirobifluorene compound has a problem of low thermal stability.

따라서 본 발명이 이루고자 하는 첫 번째 기술적 과제는 상기 종래기술의 문제점을 해결하기 위한 것으로 유기전계 발광소자의 정공수송 물질, 발광층의 도펀트 물질, 발광층의 호스트 물질, 전자수송 물질, 형광재료의 호스트, 형광소자 및 인광소자 등에 적용시 양자효율이 우수할 뿐만 아니라 열적 안정성 및 막안정성이 우수한 스파이로 화합물을 제공하는 것이다.Therefore, the first technical problem to be achieved by the present invention is to solve the problems of the prior art, the hole transport material of the organic EL device, the dopant material of the light emitting layer, the host material of the light emitting layer, the electron transport material, the host of the fluorescent material, fluorescence When applied to devices and phosphorescent devices, such as to provide a spiro compound having excellent quantum efficiency and excellent thermal stability and film stability.

본 발명이 이루고자 하는 두 번째 기술적 과제는 소자의 효율이 높고 구동 수명이 길며 열적 안정성이 높은, 상기 스파이로 화합물을 포함하는 유기전계 발광소자를 제공하는 것이다.The second technical problem to be achieved by the present invention is to provide an organic electroluminescent device comprising the spiro compound having high efficiency of the device, long drive life and high thermal stability.

본 발명은 하기 화학식 1로 표시되는 스파이로 화합물을 제공한다.The present invention provides a spiro compound represented by the following formula (1).

Figure pat00001
Figure pat00001

상기 화학식 1에서, In Chemical Formula 1,

R1 내지 R6은 서로 동일하거나 다르고, 모두 수소원자일 수 없으며,R 1 to R 6 are the same as or different from each other, and all may not be a hydrogen atom,

R1 내지 R6 중 적어도 하나는 각각 독립적으로

Figure pat00002
,
Figure pat00003
,
Figure pat00004
, 또는
Figure pat00005
이고, R1 내지 R6 중 나머지는 각각 독립적으로 수소원자, C1-9의 알킬기, C6 -30의 아릴기 또는 C5 -30의 헤테로 아릴기이며,R 1 to R 6 At least one of each independently
Figure pat00002
,
Figure pat00003
,
Figure pat00004
, or
Figure pat00005
R 1 to R 6 The remaining are each independently a hydrogen atom, a heteroaryl group of the C 1-9 alkyl group, C 6 -30 aryl group, or C 5 -30 of,

또한 R1 내지 R6 중 적어도 하나는 각각 독립적으로 이웃한 벤젠고리의 탄소원자와 결합하여 함께 접합된(fused) 방향족 고리 또는 접합된(fused) 헤테로 방향족 고리를 형성할 수 있으며, And R 1 to R 6 At least one of each may independently combine with a carbon atom of a neighboring benzene ring to form a fused aromatic ring or a fused hetero aromatic ring,

상기 R7 내지 R9는 각각 독립적으로 수소원자 또는 C1 -9의 알킬기이며,The alkyl groups of the R 7 to R 9 is a hydrogen atom or a C 1-9, each independently,

상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자, C6 -30의 아릴기 또는 C5 -30의 헤테로아릴기이다. Wherein Ar 1 to Ar 4 is a heteroaryl group are each independently a hydrogen atom, C 6 -30 aryl group or a C 5 -30.

본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00006
인 것을 특징으로 한다.According to the present invention, the R 1 to R 6 At least one of
Figure pat00006
It is characterized by that.

또한 본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00007
인 것을 특징으로 한다.In addition, according to the present invention, the R 1 to R 6 At least one of
Figure pat00007
It is characterized by that.

또한 본 발명의 일 실시예에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00008
인 것을 특징으로 한다.In addition, according to an embodiment of the present invention, the R 1 to R 6 At least one of
Figure pat00008
It is characterized by that.

또한 본 발명의 일 실시예에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00009
인 것을 특징으로 한다.In addition, according to an embodiment of the present invention, the R 1 to R 6 At least one of
Figure pat00009
It is characterized by that.

본 발명의 일 실시예에서, 상기 R1 내지 R6 중 나머지는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기이며, 상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기일 수 있고, 보다 바람직하게는 상기 R1 내지 R6 중 나머지는 수소원자이며, 상기 Ar1 내지 Ar4는 수소원자일 수 있다.In one embodiment of the present invention, the R 1 to R 6 Are each independently of the other an aryl group, a hydrogen atom or a C 6 -30, wherein Ar 1 to Ar 4 each independently can be an aryl date of a hydrogen atom or a C 6 -30, more preferably the R 1 to R 6 The remainder is a hydrogen atom, Ar 1 to Ar 4 may be a hydrogen atom.

본 발명의 일 측면은 제1전극; 제2전극; 발광층; 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 정공수송층은 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자를 제공한다. One aspect of the invention the first electrode; A second electrode; Light emitting layer; And a hole transport layer, wherein the light emitting layer includes a host and a dopant, and the hole transport layer provides an organic light emitting device comprising the spiro compound of the present invention.

본 발명의 일 실시예에 따르면, 상기 호스트는 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.According to one embodiment of the invention, the host is characterized in that it comprises a spiro compound of the invention.

본 발명의 일 실시예에 따르면, 상기 유기전계 발광소자는 전자수송층을 추가로 포함하는 것을 특징으로 한다.According to an embodiment of the present invention, the organic light emitting device further comprises an electron transport layer.

여기서, 상기 전자수송층은 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.Here, the electron transport layer is characterized in that it comprises a spiro compound of the present invention.

본 발명의 일 측면은 제1전극; 제2전극; 발광층; 전자수송층 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 호스트는 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자를 제공한다.One aspect of the invention the first electrode; A second electrode; Light emitting layer; In an organic light emitting device comprising an electron transport layer and a hole transport layer, the light emitting layer comprises a host and a dopant, the host provides an organic light emitting device, characterized in that it comprises a spiro compound of the present invention.

여기서, 상기 전자수송층은 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.Here, the electron transport layer is characterized in that it comprises a spiro compound of the present invention.

본 발명의 일시시예에 따르면, 상기 유기전계 발광소자는 정공주입층 및 전자주입층 중 하나 이상의 층을 추가로 포함할 수 있다.According to one embodiment of the present invention, the organic light emitting device may further include one or more layers of a hole injection layer and an electron injection layer.

본 발명의 일 측면은 제1전극; 제2전극; 발광층; 전자수송층 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 전자수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자를 제공한다.One aspect of the invention the first electrode; A second electrode; Light emitting layer; An organic electroluminescent device comprising an electron transport layer and a hole transport layer, wherein the light emitting layer comprises a host and a dopant, the electron transport layer provides an organic light emitting device comprising the spiro compound of claim 1.

본 발명의 스파이로 화합물은 유기전계 발광소자의 정공수송 물질, 발광층의 도펀트 물질, 발광층의 호스트 물질, 전자수송 물질, 형광재료의 호스트, 형광소자 및 인광소자 등에 적용될 수 있고, 본 발명의 스파이로 화합물을 포함하는 유기전계발광소자는 양자효율이 우수할 뿐만 아니라 열적 안정성 및 막안정성이 우수하여 소자의 구동 수명이 길고 소자 안정성이 높다.The spiro compound of the present invention can be applied to the hole transport material of the organic EL device, the dopant material of the light emitting layer, the host material of the light emitting layer, the electron transport material, the host of the fluorescent material, the fluorescent device and the phosphorescent device, etc. The organic light emitting device including the compound not only has excellent quantum efficiency, but also has excellent thermal stability and film stability, so that the driving life of the device is long and the device stability is high.

도 1은 본 발명에 따른 유기전계 발광소자의 구조를 개략적으로 나타낸 도면이다.
도 2는 본 발명에 따른 실시예와 비교예의 효율 및 휘도를 나타낸 도면이다.
1 is a view schematically showing the structure of an organic light emitting device according to the present invention.
2 is a view showing the efficiency and luminance of the Examples and Comparative Examples according to the present invention.

이하 본 발명에 따른 스파이로 화합물 및 이를 포함하는 유기전계 발광소자의 바람직한 실시예를 화학식 또는 첨부도면을 참조하여 상세히 설명하기로 한다.Hereinafter, a preferred embodiment of a spiro compound and an organic light emitting device including the same according to the present invention will be described in detail with reference to the formula or the accompanying drawings.

본 발명은 하기 화학식 1로 표시되는 스파이로 화합물을 제공한다. The present invention provides a spiro compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure pat00010
Figure pat00010

상기 화학식 1에서, In Chemical Formula 1,

R1 내지 R6은 서로 동일하거나 다르고, 모두 수소원자일 수 없으며,R 1 to R 6 are the same as or different from each other, and all may not be a hydrogen atom,

R1 내지 R6 중 적어도 하나는 각각 독립적으로

Figure pat00011
,
Figure pat00012
,
Figure pat00013
, 또는
Figure pat00014
이고, 상기 R1 내지 R6 중 나머지는 각각 독립적으로 수소원자, C1 -9의 알킬기, C6 -30의 아릴기 또는 C5 -30의 헤테로 아릴기이며,R 1 to R 6 At least one of each independently
Figure pat00011
,
Figure pat00012
,
Figure pat00013
, or
Figure pat00014
And R 1 to R 6 The remaining are each independently a hydrogen atom, a heteroaryl group of the alkyl group of C 1 -9, C 6 -30 aryl group or a C 5 -30,

또한 R1 내지 R6 중 적어도 하나는 각각 독립적으로 이웃한 벤젠고리의 탄소원자와 결합하여 함께 접합된(fused) 방향족 고리 또는 접합된(fused) 헤테로 방향족 고리를 형성할 수 있으며,And R 1 to R 6 At least one of each may independently combine with a carbon atom of a neighboring benzene ring to form a fused aromatic ring or a fused hetero aromatic ring,

상기 R7 내지 R9는 각각 독립적으로 수소원자 또는 C1 -9의 알킬기이며,The alkyl groups of the R 7 to R 9 is a hydrogen atom or a C 1-9, each independently,

상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자, C6 -30의 아릴기 또는 C5 -30의 헤테로아릴기이다. Wherein Ar 1 to Ar 4 is a heteroaryl group are each independently a hydrogen atom, C 6 -30 aryl group or a C 5 -30.

본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00015
인 것을 특징으로 한다.According to the present invention, the R 1 to R 6 At least one of
Figure pat00015
It is characterized by that.

또한 본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00016
인 것을 특징으로 한다.In addition, according to the present invention, the R 1 to R 6 At least one of
Figure pat00016
It is characterized by that.

또한 본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00017
인 것을 특징으로 한다.In addition, according to the present invention, the R 1 to R 6 At least one of
Figure pat00017
It is characterized by that.

또한 본 발명에 따르면, 상기 R1 내지 R6 중 적어도 하나는

Figure pat00018
인 것을 특징으로 한다.In addition, according to the present invention, the R 1 to R 6 At least one of
Figure pat00018
It is characterized by that.

본 발명에서, 상기 R1 내지 R6 중 나머지는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기이며, 상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기일 수 있으며, 보다 바람직하게는 상기 R1 내지 R6 중 나머지는 수소원자이며, 상기 Ar1 내지 Ar4는 수소원자일 수 있다.In the present invention, the R 1 to R 6 Are each independently of the other an aryl group, a hydrogen atom or a C 6 -30, wherein Ar 1 to Ar 4 each independently can be an aryl date of a hydrogen atom or a C 6 -30, more preferably the R 1 to R 6 The remainder is a hydrogen atom, Ar 1 to Ar 4 may be a hydrogen atom.

상기 R1 내지 R6 및 Ar1 내지 Ar4의 C6 -30의 아릴기로서의 구체적인 예로서는, 페닐기, 1-나프틸기, 2-나프틸기, 1-안트릴기, 2-안트릴기, 9-안트릴기, 1-페난트릴기, 2-페난트릴기, 3-페난트릴기, 4-페난트릴기, 9-페난트릴기, 1-나프타센일기, 2-나프타센일기, 9-나프타센일기, 1-피렌일기, 2-피렌일기, 4-피렌일기, 2-바이페닐일기, 3-바이페닐일기, 4-바이페닐일기, p-터페닐-4-일기, p-터페닐-3-일기, p-터페닐-2-일기, m-터페닐-4-일기, m-터페닐-3-일기, m-터페닐-2-일기, o-톨릴기, m-톨릴기, p-톨릴기, p-tert-뷰틸페닐기, p-(2-페닐프로필)페닐기, 3-메틸-2-나프틸기, 4-메틸-1-나프틸기, 4-메틸-1-안트릴기, 4-메틸바이페닐일기 또는 4-tert-뷰틸-p-터페닐-4-일기 등을 들 수 있다.R 1 to R 6 And Ar 1 to Ar 4 of the C 6 -30 aryl group, as specific examples, a phenyl group, 1-naphthyl, 2-naphthyl group, 1-anthryl group, 2-anthryl group, 9-anthryl group, 1- Phenanthryl group, 2-phenanthryl group, 3-phenanthryl group, 4-phenanthryl group, 9-phenanthryl group, 1-naphthacenyl group, 2-naphthacenyl group, 9-naphthacenyl group, 1-pyrenyl group , 2-pyrenyl group, 4-pyrenyl group, 2-biphenylyl group, 3-biphenylyl group, 4-biphenylyl group, p-terphenyl-4-yl group, p-terphenyl-3-yl group, p-terter Phenyl-2-yl group, m-terphenyl-4-yl group, m-terphenyl-3-yl group, m-terphenyl-2-yl group, o-tolyl group, m-tolyl group, p-tolyl group, p- tert-butylphenyl group, p- (2-phenylpropyl) phenyl group, 3-methyl-2-naphthyl group, 4-methyl-1-naphthyl group, 4-methyl-1-anthryl group, 4-methylbiphenylyl group or 4-tert-butyl-p-terphenyl-4-yl group etc. are mentioned.

또한 상기 R1 내지 R6 및 Ar1 내지 Ar4의 C6 -30의 헤테로아릴기의 구체적인 예로서는 1-피롤릴기, 2-피롤릴기, 3-피롤릴기, 피라진일기, 피리미딜기, 피리다질기, 2-피리딘일기, 3-피리딘일기, 4-피리딘일기, 1-인돌릴기, 2-인돌릴기, 3-인돌릴기, 4-인돌릴기, 5-인돌릴기, 6-인돌릴기, 7-인돌릴기, 1-아이소인돌릴기, 2-아이소인돌릴기, 3-아이소인돌릴기, 4-아이소인돌릴기, 5-아이소인돌릴기, 6-아이소인돌릴기, 7-아이소인돌릴기, 2-퓨릴기, 3-퓨릴기, 2-벤조퓨란일기, 3-벤조퓨란일기, 4-벤조퓨란일기, 5-벤조퓨란일기, 6-벤조퓨란일기, 7-벤조퓨란일기, 1-아이소벤조퓨란일기, 3-아이소벤조퓨란일기, 4-아이소벤조퓨란일기, 5-아이소벤조퓨란일기, 6-아이소벤조퓨란일기, 7-아이소벤조퓨란일기, 1-다이벤조퓨란일기, 2-다이벤조퓨란일기, 3-다이벤조퓨란일기, 6-다이벤조퓨란일기, 7-다이벤조퓨란일기, 8-다이벤조퓨란일기, 9-다이벤조퓨란일기, 2-벤조사이오펜, 3-벤조사이오펜, 4-벤조사이오펜, 5-벤조사이오펜, 6-벤조사이오펜, 7-벤조사이오펜, 1-다이벤조사이오펜, 2-다이벤조사이오펜, 3-다이벤조사이오펜, 4-다이벤조사이오펜, 6-다이벤조사이오펜, 7-다이벤조사이오펜, 8-다이벤조사이오펜, 9-다이벤조사이오펜, 2-벤조포스폴, 3-벤조포스폴, 4-벤조포스폴, 5-벤조포스폴, 6-벤조포스폴, 7-벤조포스폴, 1-다이벤조포스폴, 2-다이벤조포스폴, 3-다이벤조포스폴, 4-이벤조포스폴, 6-이벤조포스폴, 7-다이벤조포스폴, 8-다이벤조포스폴, 9-이벤조포스폴, 2-벤조포스폴옥사이드, 3-벤조포스폴옥사이드, 4-벤조포스폴옥사이드, 5-벤조포스폴옥사이드, 6-벤조포스폴옥사이드, 7-벤조포스폴옥사이드, 1-다이벤조포스폴옥사이드, 2-다이벤조포스폴옥사이드, 3-다이벤조포스폴옥사이드, 4-다이벤조포스폴옥사이드, 6-다이벤조포스폴옥사이드, 7-다이벤조포스폴옥사이드, 8-다이벤조포스폴옥사이드, 9-다이벤조포스폴옥사이드, 퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀릴기, 2-퀴녹살린일기, 5-퀴녹살린일기, 6-퀴녹살린일기, 1-페난트리딘일기, 2-페난트리딘일기, 3-페난트리딘일기, 4-페난트리딘일기, 6-페난트리딘일기, 7-페난트리딘일기, 8-페난트리딘일기, 9-페난트리딘일기, 10-페난트리딘일기, 1-아크리딘일기, 2-아크리딘일기, 3-아크리딘일기, 4-아크리딘일기, 9-아크리딘일기, 1,7-페난트롤린-2-일기, 1,7-페난트롤린-3-일기, 1,7-페난트롤린-4-일기, 1,7-페난트롤린-5-일기, 1,7-페난트롤린-6-일기, 1,7-페난트롤린-8-일기, 1,7-페난트롤린-9-일기, 1,7-페난트롤린-10-일기, 1,8-페난트롤린-2-일기, 1,8-페난트롤린-3-일기, 1,8-페난트롤린-4-일기, 1,8-페난트롤린-5-일기, 1,8-페난트롤린-6-일기, 1,8-페난트롤린-7-일기, 1,8-페난트롤린-9-일기, 1,8-페난트롤린-10-일기, 1,9-페난트롤린-2-일기, 1,9-페난트롤린-3-일기, 1,9-페난트롤린-4-일기, 1,9-페난트롤린-5-일기, 1,9-페난트롤린-6-일기, 1,9-페난트롤린-7-일기, 1,9-페난트롤린-8-일기, 1,9-페난트롤린-10-일기, 1,10-페난트롤린-2-일기, 1,10-페난트롤린-3-일기, 1,10-페난트롤린-4-일기, 1,10-페난트롤린-5-일기, 2,9-페난트롤린-1-일기, 2,9-페난트롤린-3-일기, 2,9-페난트롤린-4-일기, 2,9-페난트롤린-5-일기, 2,9-페난트롤린-6-일기, 2,9-페난트롤린-7-일기, 2,9-페난트롤린-8-일기, 2,9-페난트롤린-10-일기, 2,8-페난트롤린-1-일기, 2,8-페난트롤린-3-일기, 2,8-페난트롤린-4-일기, 2,8-페난트롤린-5-일기, 2,8-페난트롤린-6-일기, 2,8-페난트롤린-7-일기, 2,8-페난트롤린-9-일기, 2,8-페난트롤린일기, 2,7-페난트롤린-1-일기, 2,7-페난트롤린-3-일기, 2,7-페난트롤린-4-일기, 2,7-페난트롤린-5-일기, 2,7-페난트롤린-6-일기, 2,7-페난트롤린-8-일기, 2,7-페난트롤린-9-일기, 2,7-페난트롤린-10-일기, 1-페나진일기, 2-페나진일기, 1-페노싸이아진일기, 2-페노싸이아진일기, 3-페노싸이아진일기, 4-페노싸이아진일기, 10-페노싸이아진일기, 1-페녹사진일기, 2-페녹사진일기, 3-페녹사진일기, 4-페녹사진일기, 10-페녹사진일기, 2-옥사졸릴기, 4-옥사졸릴기, 5-옥사졸릴기, 2-옥사다이아졸릴기, 5-옥사다이아졸릴기, 3-퓨라잔일기, 2-싸이엔일기, 3-싸이엔일기, 2-메틸피롤-1-일기, 2-메틸피롤-3-일기, 2-메틸피롤-4-일기, 2-메틸피롤-5-일기, 3-메틸피롤-1-일기, 3-메틸피롤-2-일기, 3-메틸피롤-4-일기, 3-메틸피롤-5-일기, 2-tert-뷰틸피롤-4-일기, 3-(2-페닐프로필)피롤-1-일기, 2-메틸-1-인돌릴기, 4-메틸-1-인돌릴기, 2-메틸-3-인돌릴기, 4-메틸-3-인돌릴기, 2-tert-뷰틸-1-인돌릴기, 4-tert-뷰틸-1-인돌릴기, 2-tert-뷰틸-3-인돌릴기 또는 4-tert-뷰틸-3-인돌릴기 등을 들 수 있다.Also R 1 to R 6 And Ar 1 to Ar 4 of the C 6 -30 Specific examples of the heteroaryl group of 1-pyrrolyl group, 2-pyrrolyl group, 3-pyrrolyl group, pyrazinyl the group, pyrimidinyl group, a pyrido chewy, 2-pyridine group, 3 -Pyridinyl group, 4-pyridinyl group, 1-indolyl group, 2-indolyl group, 3-indolyl group, 4-indolyl group, 5-indolyl group, 6-indolyl group, 7-indolyl group, 1-isoindoleyl group , 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-isoindolyl group, 7-isoindolyl group, 2-furyl group, 3- Furyl group, 2-benzofuranyl group, 3-benzofuranyl group, 4-benzofuranyl group, 5-benzofuranyl group, 6-benzofuranyl group, 7-benzofuranyl group, 1-isobenzofuranyl group, 3-isobenzo Furanyl group, 4-isobenzofuranyl group, 5-isobenzofuranyl group, 6-isobenzofuranyl group, 7-isobenzofuranyl group, 1-dibenzofuranyl group, 2-dibenzofuranyl group, 3-dibenzofuran Diary, 6-dibenzofuranyl group, 7-dibenzo Lanyl group, 8-dibenzofuranyl group, 9-dibenzofuranyl group, 2-benzothiophene, 3-benzothiophene, 4-benzothiophene, 5-benzothiophene, 6-benzothiophene, 7-benzo Ciophene, 1-dibenzothiophene, 2-dibenzothiophene, 3-dibenzothiophene, 4-dibenzothiophene, 6-dibenzothiophene, 7-dibenzothiophene, 8-dibenzosai Offen, 9-dibenzothiophene, 2-benzophosphole, 3-benzophosphole, 4-benzophosphole, 5-benzophosphole, 6-benzophosphole, 7-benzophosphole, 1-dibenzoforce Pole, 2-Dibenzophosphole, 3-Dibenzophosphole, 4-Ibenzophosphole, 6-Ibenzophosphole, 7-Dibenzophosphole, 8-Dibenzophosphole, 9-Ibenzophosphole, 2- Benzophosphole oxide, 3-benzophosphole oxide, 4-benzophosphole oxide, 5-benzophosphole oxide, 6-benzophosphole oxide, 7-benzophosphole oxide, 1-dibenzophosphole oxide, 2- Dibenzophosphoxide, 3-diben Crude phosphol oxide, 4-dibenzophosphole oxide, 6-dibenzophosphole oxide, 7-dibenzophosphole oxide, 8-dibenzophosphole oxide, 9-dibenzophospholeoxide, quinolyl group, 3- Quinolyl, 4-quinolyl, 5-quinolyl, 6-quinolyl, 7-quinolyl, 8-quinolyl, 1-isoquinolyl, 3-isoquinolyl, 4- Isoquinolyl group, 5-isoquinolyl group, 6-isoquinolyl group, 7-isoquinolyl group, 8-isoquinolyl group, 2-quinoxalinyl group, 5-quinoxalinyl group, 6-quinoxalinyl group , 1-phenanthridinyl group, 2-phenanthridinyl group, 3-phenanthridinyl group, 4-phenanthridinyl group, 6-phenanthridinyl group, 7-phenanthridinyl group, 8-phenanthridinyl group, 9-phenanthridinyl group, 10-phenanthridinyl group, 1-acridinyl group, 2-acridinyl group, 3-acridinyl group, 4-acridinyl group, 9-acridinyl group, 1 , 7-phenanthroline-2-yl, 1,7-phenanthroline-3-yl, 1,7-phenanthroline-4-yl, 1,7-phenan Roline-5-Diary, 1,7-phenanthroline-6-diary, 1,7-phenanthroline-8-diary, 1,7-phenanthroline-9-diary, 1,7-phenanthroline- 10-diary, 1,8-phenanthroline-2-yl, 1,8-phenanthroline-3-yl, 1,8-phenanthroline-4-yl, 1,8-phenanthroline-5- Diary, 1,8-phenanthroline-6-diary, 1,8-phenanthroline-7-diary, 1,8-phenanthroline-9-diary, 1,8-phenanthroline-10-diary, 1,9-phenanthroline-2-yl, 1,9-phenanthroline-3-yl, 1,9-phenanthroline-4-yl, 1,9-phenanthroline-5-yl, 1, 9-phenanthroline-6-diary, 1,9-phenanthroline-7-diary, 1,9-phenanthroline-8-diary, 1,9-phenanthroline-10-diary, 1,10- Phenanthroline-2-yl, 1,10-phenanthroline-3-yl, 1,10-phenanthroline-4-yl, 1,10-phenanthroline-5-diary, 2,9-phenanthrole Lin-1-yl, 2,9-phenanthroline-3-yl, 2,9-phenanthroline-4-yl, 2,9-phenanthroline-5-diary, 2,9-phenanthroline- 6-diary, 2,9-phenanthroline-7-diary, 2,9-phenanthroline-8-diary, 2,9-phenanthroline-10-diary, 2,8-phenant Lin-1-yl, 2,8-phenanthroline-3-yl, 2,8-phenanthroline-4-yl, 2,8-phenanthroline-5-diary, 2,8-phenanthroline- 6-diary, 2,8-phenanthroline-7-diary, 2,8-phenanthroline-9-diary, 2,8-phenanthrolineyl group, 2,7-phenanthroline-1-yl group, 2 , 7-phenanthroline-3-yl, 2,7-phenanthroline-4-yl, 2,7-phenanthroline-5-diary, 2,7-phenanthroline-6-diary, 2,7 -Phenanthroline-8-diary, 2,7-phenanthroline-9-diary, 2,7-phenanthroline-10-diary, 1-phenazineyl group, 2-phenazinediary group, 1-phenothiazin Diary, 2-phenothiazin diary, 3-phenothiazin diary, 4-phenothiazin diary, 10-phenothiazin diary, 1-phenoxazine diary, 2-phenoxazine diary, 3-phenoxazine diary, 4- Phenoxazineyl group, 10-phenoxazineyl group, 2-oxazolyl group, 4-oxazolyl group, 5-oxazolyl group, 2-oxadiazolyl group, 5-oxadiazolyl group, 3-furazanyl group, 2- Thienyl group, 3-thienyl group, 2-methylpyrrole-1-yl group, 2-methylpyrrole-3-yl group, 2-methylpyrrole-4-yl group, 2 -Methylpyrrole-5-yl group, 3-methylpyrrole-1-yl group, 3-methylpyrrole-2-yl group, 3-methylpyrrole-4-yl group, 3-methylpyrrole-5-yl group, 2-tert-butylpyrrole -4-yl group, 3- (2-phenylpropyl) pyrrole-1-yl group, 2-methyl-1-indolyl group, 4-methyl-1-indolyl group, 2-methyl-3-indolyl group, 4-methyl- 3-indolyl group, 2-tert-butyl-1-indolyl group, 4-tert-butyl-1-indolyl group, 2-tert-butyl-3-indolyl group or 4-tert-butyl-3-indolyl group Can be mentioned.

또한 상기 R1 내지 R9의 C1 -9의 알킬기의 구체적인 예로서는 메틸, 에틸, n-프로필, n-펜틸기, n-뷰틸, n-헥실기, n-헵틸기, n-옥틸기, 아이소프로필기, sec-뷰틸기, 아이소뷰틸기, tert-뷰틸기 등을 들 수 있다.In addition, the R 1 to R 9 a C 1 alkyl group and specific examples include methyl, ethyl of -9, n- propyl, n- pentyl, n- butyl, n- hexyl, n- heptyl, n- octyl, iso A propyl group, sec-butyl group, isobutyl group, tert- butyl group, etc. are mentioned.

기존의 스파이로바이플루오렌(spirobifluorene)을 포함하는 스파이로 화합물의 문제점을 개선하기 위하여 본 발명에서는 스파이로 구조의 장점을 가지고 보다 열적 안정성 및 막안정성이 개선된 새로운 재료로서 이중스파이로 구조를 갖는 이중 스파이로바이플루오렌 계열의 구조를 개발하였다. 단일 스파이로 구조의 스파이로바이플루오렌에 비하여 이중 스파이로바이플루오렌 구조를 갖는 유기화합물을 통하여 열적 안정성을 개선하였다. 이중스파이로 구조를 갖는 이중 스파이로바이플루오렌 구조의 경우 보다 강직한 구조로 되어 있고, 결정화가 어려운 구조로 되어 있어, 막 형성시 결정화를 방지할 수 있으며, 이에 따라 열적 안정성도 개선할 수 있었다. In order to improve the problem of the spiro compound containing the existing spirobifluorene (spirobifluorene) in the present invention has a double spiro structure as a new material having the advantages of the spiro structure and improved thermal stability and film stability A double spirobifluorene-based structure has been developed. Thermal stability was improved through organic compounds having a double spirobifluorene structure compared to a single spirobifluorene structure. The double spirobifluorene structure having a double spiro structure has a more rigid structure and a structure that is difficult to crystallize, thereby preventing crystallization during film formation, thereby improving thermal stability. .

이하에서, 본 발명의 스파이로 화합물의 1 내지 240의 구조식을 표 1에 예시하지만, 본 발명이 이들 화합물로 한정되는 것은 아니다.Hereinafter, although the structural formula of 1-240 of the spiro compound of this invention is illustrated in Table 1, this invention is not limited to these compounds.

화합물compound 화학 구조식Chemical structural formula 화합물compound 화학 구조식Chemical structural formula 1One

Figure pat00019
Figure pat00019
22
Figure pat00020
Figure pat00020
33
Figure pat00021
Figure pat00021
44
Figure pat00022
Figure pat00022
55
Figure pat00023
Figure pat00023
66
Figure pat00024
Figure pat00024
77
Figure pat00025
Figure pat00025
88
Figure pat00026
Figure pat00026
99
Figure pat00027
Figure pat00027
1010
Figure pat00028
Figure pat00028
1111
Figure pat00029
Figure pat00029
1212
Figure pat00030
Figure pat00030
1313
Figure pat00031
Figure pat00031
1414
Figure pat00032
Figure pat00032
1515
Figure pat00033
Figure pat00033
1616
Figure pat00034
Figure pat00034
1717
Figure pat00035
Figure pat00035
1818
Figure pat00036
Figure pat00036
1919
Figure pat00037
Figure pat00037
2020
Figure pat00038
Figure pat00038
2121
Figure pat00039
Figure pat00039
2222
Figure pat00040
Figure pat00040
2323
Figure pat00041
Figure pat00041
2424
Figure pat00042
Figure pat00042
2525
Figure pat00043
Figure pat00043
2626
Figure pat00044
Figure pat00044
2727
Figure pat00045
Figure pat00045
2828
Figure pat00046
Figure pat00046
2929
Figure pat00047
Figure pat00047
3030
Figure pat00048
Figure pat00048
3131
Figure pat00049
Figure pat00049
3232
Figure pat00050
Figure pat00050
3333
Figure pat00051
Figure pat00051
3434
Figure pat00052
Figure pat00052
3535
Figure pat00053
Figure pat00053
3636
Figure pat00054
Figure pat00054
3737
Figure pat00055
Figure pat00055
3838
Figure pat00056
Figure pat00056
3939
Figure pat00057
Figure pat00057
4040
Figure pat00058
Figure pat00058
4141
Figure pat00059
Figure pat00059
4242
Figure pat00060
Figure pat00060
4343
Figure pat00061
Figure pat00061
4444
Figure pat00062
Figure pat00062
4545
Figure pat00063
Figure pat00063
4646
Figure pat00064
Figure pat00064
4747
Figure pat00065
Figure pat00065
4848
Figure pat00066
Figure pat00066
4949
Figure pat00067
Figure pat00067
5050
Figure pat00068
Figure pat00068
5151
Figure pat00069
Figure pat00069
5252
Figure pat00070
Figure pat00070
5353
Figure pat00071
Figure pat00071
5454
Figure pat00072
Figure pat00072
5555
Figure pat00073
Figure pat00073
5656
Figure pat00074
Figure pat00074
5757
Figure pat00075
Figure pat00075
5858
Figure pat00076
Figure pat00076
5959
Figure pat00077
Figure pat00077
6060
Figure pat00078
Figure pat00078
6161
Figure pat00079
Figure pat00079
6262
Figure pat00080
Figure pat00080
6363
Figure pat00081
Figure pat00081
6464
Figure pat00082
Figure pat00082
6565
Figure pat00083
Figure pat00083
6666
Figure pat00084
Figure pat00084
6767
Figure pat00085
Figure pat00085
6868
Figure pat00086
Figure pat00086
6969
Figure pat00087
Figure pat00087
7070
Figure pat00088
Figure pat00088
7171
Figure pat00089
Figure pat00089
7272
Figure pat00090
Figure pat00090
7373
Figure pat00091
Figure pat00091
7474
Figure pat00092
Figure pat00092
7575
Figure pat00093
Figure pat00093
7676
Figure pat00094
Figure pat00094
7777
Figure pat00095
Figure pat00095
7878
Figure pat00096
Figure pat00096
7979
Figure pat00097
Figure pat00097
8080
Figure pat00098
Figure pat00098
8181
Figure pat00099
Figure pat00099
8282
Figure pat00100
Figure pat00100
8383
Figure pat00101
Figure pat00101
8484
Figure pat00102
Figure pat00102
8585
Figure pat00103
Figure pat00103
8686
Figure pat00104
Figure pat00104
8787
Figure pat00105
Figure pat00105
8888
Figure pat00106
Figure pat00106
8989
Figure pat00107
Figure pat00107
9090
Figure pat00108
Figure pat00108
9191
Figure pat00109
Figure pat00109
9292
Figure pat00110
Figure pat00110
9393
Figure pat00111
Figure pat00111
9494
Figure pat00112
Figure pat00112
9595
Figure pat00113
Figure pat00113
9696
Figure pat00114
Figure pat00114
9797
Figure pat00115
Figure pat00115
9898
Figure pat00116
Figure pat00116
9999
Figure pat00117
Figure pat00117
100100
Figure pat00118
Figure pat00118
101101
Figure pat00119
Figure pat00119
102102
Figure pat00120
Figure pat00120
103103
Figure pat00121
Figure pat00121
104104
Figure pat00122
Figure pat00122
105105
Figure pat00123
Figure pat00123
106106
Figure pat00124
Figure pat00124
107107
Figure pat00125
Figure pat00125
108108
Figure pat00126
Figure pat00126
109109
Figure pat00127
Figure pat00127
110110
Figure pat00128
Figure pat00128
111111
Figure pat00129
Figure pat00129
112112
Figure pat00130
Figure pat00130
113113
Figure pat00131
Figure pat00131
114114
Figure pat00132
Figure pat00132
115115
Figure pat00133
Figure pat00133
116116
Figure pat00134
Figure pat00134
117117
Figure pat00135
Figure pat00135
118118
Figure pat00136
Figure pat00136
119119
Figure pat00137
Figure pat00137
120120
Figure pat00138
Figure pat00138
121121
Figure pat00139
Figure pat00139
122122
Figure pat00140
Figure pat00140
123123
Figure pat00141
Figure pat00141
124124
Figure pat00142
Figure pat00142
125125
Figure pat00143
Figure pat00143
126126
Figure pat00144
Figure pat00144
127127
Figure pat00145
Figure pat00145
128128
Figure pat00146
Figure pat00146
129129
Figure pat00147
Figure pat00147
130130
Figure pat00148
Figure pat00148
131131
Figure pat00149
Figure pat00149
132132
Figure pat00150
Figure pat00150
133133
Figure pat00151
Figure pat00151
134134
Figure pat00152
Figure pat00152
135135
Figure pat00153
Figure pat00153
136136
Figure pat00154
Figure pat00154
137137
Figure pat00155
Figure pat00155
138138
Figure pat00156
Figure pat00156
139139
Figure pat00157
Figure pat00157
140140
Figure pat00158
Figure pat00158
141141
Figure pat00159
Figure pat00159
142142
Figure pat00160
Figure pat00160
143143
Figure pat00161
Figure pat00161
144144
Figure pat00162
Figure pat00162
145145
Figure pat00163
Figure pat00163
146146
Figure pat00164
Figure pat00164
147147
Figure pat00165
Figure pat00165
148148
Figure pat00166
Figure pat00166
149149
Figure pat00167
Figure pat00167
150150
Figure pat00168
Figure pat00168
151151
Figure pat00169
Figure pat00169
152152
Figure pat00170
Figure pat00170
153153
Figure pat00171
Figure pat00171
154154
Figure pat00172
Figure pat00172
155155
Figure pat00173
Figure pat00173
156156
Figure pat00174
Figure pat00174
157157
Figure pat00175
Figure pat00175
158158
Figure pat00176
Figure pat00176
159159
Figure pat00177
Figure pat00177
160160
Figure pat00178
Figure pat00178
161161
Figure pat00179
Figure pat00179
162162
Figure pat00180
Figure pat00180
163163
Figure pat00181
Figure pat00181
164164
Figure pat00182
Figure pat00182
165165
Figure pat00183
Figure pat00183
166166
Figure pat00184
Figure pat00184
167167
Figure pat00185
Figure pat00185
168168
169169
Figure pat00187
Figure pat00187
170170
Figure pat00188
Figure pat00188
171171
Figure pat00189
Figure pat00189
172172
Figure pat00190
Figure pat00190
173173
Figure pat00191
Figure pat00191
174174
Figure pat00192
Figure pat00192
175175
Figure pat00193
Figure pat00193
176176
Figure pat00194
Figure pat00194
177177
Figure pat00195
Figure pat00195
178178
Figure pat00196
Figure pat00196
179179
Figure pat00197
Figure pat00197
180180
Figure pat00198
Figure pat00198
181181
Figure pat00199
Figure pat00199
182182
Figure pat00200
Figure pat00200
183183
Figure pat00201
Figure pat00201
184184
Figure pat00202
Figure pat00202
185185
Figure pat00203
Figure pat00203
186186
Figure pat00204
Figure pat00204
187187
Figure pat00205
Figure pat00205
188188
Figure pat00206
Figure pat00206
189189 190190
Figure pat00208
Figure pat00208
191191
Figure pat00209
Figure pat00209
192192
Figure pat00210
Figure pat00210
193193
Figure pat00211
Figure pat00211
194194
Figure pat00212
Figure pat00212
195195
Figure pat00213
Figure pat00213
196196
Figure pat00214
Figure pat00214
197197
Figure pat00215
Figure pat00215
198198
Figure pat00216
Figure pat00216
199199
Figure pat00217
Figure pat00217
200200
Figure pat00218
Figure pat00218
201201
Figure pat00219
Figure pat00219
202202
Figure pat00220
Figure pat00220
203203
Figure pat00221
Figure pat00221
204204
Figure pat00222
Figure pat00222
205205
Figure pat00223
Figure pat00223
206206
Figure pat00224
Figure pat00224
207207
Figure pat00225
Figure pat00225
208208
Figure pat00226
Figure pat00226
209209
Figure pat00227
Figure pat00227
210210
Figure pat00228
Figure pat00228
211211
Figure pat00229
Figure pat00229
212212
Figure pat00230
Figure pat00230
213213
Figure pat00231
Figure pat00231
214214
Figure pat00232
Figure pat00232
215215
Figure pat00233
Figure pat00233
216216
Figure pat00234
Figure pat00234
217217
Figure pat00235
Figure pat00235
218218
Figure pat00236
Figure pat00236
219219
Figure pat00237
Figure pat00237
220220
Figure pat00238
Figure pat00238
221221
Figure pat00239
Figure pat00239
222222
Figure pat00240
Figure pat00240
223223
Figure pat00241
Figure pat00241
224224
Figure pat00242
Figure pat00242
225225
Figure pat00243
Figure pat00243
226226
Figure pat00244
Figure pat00244
227227
Figure pat00245
Figure pat00245
228228
Figure pat00246
Figure pat00246
229229
Figure pat00247
Figure pat00247
230230
Figure pat00248
Figure pat00248
231231
Figure pat00249
Figure pat00249
232232
Figure pat00250
Figure pat00250
233233
Figure pat00251
Figure pat00251
234234
Figure pat00252
Figure pat00252
235235
Figure pat00253
Figure pat00253
236236
Figure pat00254
Figure pat00254
237237
Figure pat00255
Figure pat00255
238238
Figure pat00256
Figure pat00256
239239
Figure pat00257
Figure pat00257
240240
Figure pat00258
Figure pat00258

본 발명에 따른 유기전계 발광소자를 첨부도면을 참조하여 설명하기로 한다. 도 1은 본 발명의 유기전계 발광소자의 구조를 개략적으로 나타낸 도면이다. 상기한 화학식 1로 표시되는 스파이로 화합물을 포함하는 유기전계 발광소자는 다양한 구조로 실현될 수 있다. An organic EL device according to the present invention will be described with reference to the accompanying drawings. 1 is a view schematically showing the structure of an organic EL device of the present invention. The organic light emitting device including the spiro compound represented by Chemical Formula 1 may be realized in various structures.

본 발명의 일 측면에 따르면 유기전계 발광소자는 제1전극(110); 제2전극(150); 발광층(130); 및 정공수송층(120)을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 정공수송층(120)은 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.According to an aspect of the present invention, the organic light emitting device includes: a first electrode 110; Second electrode 150; Light emitting layer 130; And a hole transport layer 120, wherein the light emitting layer is an organic light emitting device including a host and a dopant, and the hole transport layer 120 is characterized in that it comprises a spiro compound of the present invention.

본 발명의 일 실시예에 따르면, 상기 호스트는 본 발명의 스파이로 화합물을 포함할 수 있다.According to an embodiment of the present invention, the host may include the spiro compound of the present invention.

또한 본 발명의 일 실시예에 따르면, 상기 유기전계 발광소자는 전자수송층(140)을 추가로 포함할 수 있다.In addition, according to an embodiment of the present invention, the organic light emitting device may further include an electron transport layer (140).

여기서, 상기 전자수송층(140)은 본 발명의 스파이로 화합물을 포함할 수 있다.Here, the electron transport layer 140 may include a spiro compound of the present invention.

또한 본 발명의 일 측면은 유기전계 발광소자는 제1전극(110); 제2전극(150); 발광층(130); 전자수송층(140) 및 정공수송층(120)을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 호스트는 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.In addition, an aspect of the present invention, the organic light emitting device includes a first electrode (110); Second electrode 150; Light emitting layer 130; An electron transport layer 140 and a hole transport layer 120, the light emitting layer is an organic electroluminescent device comprising a host and a dopant, the host is characterized in that it comprises a spiro compound of the present invention.

여기서 상기 전자수송층은 본 발명의 스파이로 화합물을 포함하는 것을 특징으로 한다.The electron transport layer is characterized in that it comprises a spiro compound of the present invention.

본 발명의 일 실시예에 따른 유기전계 발광소자는 정공주입층 및 전자주입층 중에서 선택된 1종 이상의 층을 추가로 포함하여 발광효율을 향상시킬 수 있다.The organic light emitting device according to an embodiment of the present invention may further include at least one layer selected from a hole injection layer and an electron injection layer to improve luminous efficiency.

또한 본 발명의 일 측면은 제1전극; 제2전극; 발광층; 전자수송층 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서, 상기 전자수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자를 제공할 수 있다.In addition, one aspect of the invention the first electrode; A second electrode; Light emitting layer; An organic light emitting device comprising an electron transport layer and a hole transport layer, wherein the light emitting layer includes a host and a dopant, wherein the electron transport layer includes the spiro compound of claim 1. have.

유기전계 발광소자는 바람직하게는 투명기판에 의하여 지지된다. 투명기판의 재료로는 양호한 기계적 강도, 열안정성 및 투명성을 갖는 한 특별한 제한은 없다. 구체적인 예를 들면, 유리, 투명 플라스틱 필름 등을 사용할 수 있다.The organic light emitting device is preferably supported by a transparent substrate. The material of the transparent substrate is not particularly limited as long as it has good mechanical strength, thermal stability and transparency. For example, glass, a transparent plastic film, etc. can be used.

본 발명의 유기전계 발광소자의 양극재료로서는 4eV 이상의 일함수를 갖는 금속, 합금, 전기전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는 금속인 Au 또는 CuI, ITO(인듐 주석 산화물), SnO2 및 ZnO와 같은 투명 전도성 재료를 들 수 있다. 양극 필름의 두께는 10 내지 200nm 가 바람직하다.As the anode material of the organic EL device of the present invention, a metal, an alloy, an electrically conductive compound having a work function of 4 eV or more, or a mixture thereof can be used. Specifically, transparent conductive materials such as Au or CuI, ITO (indium tin oxide), SnO 2 and ZnO which are metals are mentioned. The thickness of the positive electrode film is preferably 10 to 200 nm.

본 발명의 유기전계 발광소자의 음극 재료로서는 4eV 미만의 일함수를 갖는 금속, 합금, 전기 전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는, Na, Na-K 합금, 칼슘, 마그네슘, 리튬, 리튬 합금, 인듐, 알루미늄, 마그네슘 합금, 알루미늄 합금을 들 수 있다. 이외에, 알루미늄/AlO2, 알루미늄/리튬, 마그네슘/은 또는 마그네슘/인듐 등도 사용될 수 있다. 음극필름의 두께는 10 내지 200nm 가 바람직하다. 유기 EL 소자의 발광효율을 높이기 위해서는 하나 이상의 전극은 바람직하게는 10% 이상의 광투과율을 가지는 것이 바람직하다. 전극의 쉬트저항은 바람직하게는 수백 Ω/mm 이하이다. 전극의 두께는 10nm 내지 1㎛, 보다 바람직하게는 10 내지 400nm 이다. 이러한 전극은 화학적 기상증착(CVD), 물리적 기상증착(PVD) 등의 기상증착법 또는 스퍼터링법을 통하여 상기한 전극 재료를 박막으로 형성하여 제조할 수 있다.As a negative electrode material of the organic EL device of the present invention, a metal, an alloy, an electrically conductive compound or a mixture thereof having a work function of less than 4 eV can be used. Specifically, Na, Na-K alloy, calcium, magnesium, lithium, lithium alloy, indium, aluminum, magnesium alloy, aluminum alloy is mentioned. In addition, aluminum / AlO 2 , aluminum / lithium, magnesium / silver or magnesium / indium may be used. The thickness of the negative electrode film is preferably 10 to 200 nm. In order to increase the luminous efficiency of the organic EL device, at least one electrode preferably has a light transmittance of 10% or more. The sheet resistance of the electrode is preferably several hundred Ω / mm or less. The thickness of the electrode is 10 nm to 1 m, more preferably 10 to 400 nm. Such an electrode may be manufactured by forming the above electrode material into a thin film through vapor deposition or sputtering such as chemical vapor deposition (CVD), physical vapor deposition (PVD), or the like.

본 발명의 정공수송층 또는 정공주입층은 정공 수송 물질 및 정공 주입 물질로서 광전도성 재료 중에서 정공 수송 물질로서 통상적으로 사용되는 재료 및 유기 EL 소자의 정공 수송층 또는 정공 주입층의 형성에 사용되는 공지된 재료를 포함할 수 있다. 예를 들면, N,N-dicarbazolyl-3,5-benzene(mCP), poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS), N, N’-di(1-naphthyl)-N,N’-diphenylbenzidine(NPD), N,N'-디페닐-N,N'-디(3-메틸페닐)-4,4'-디아미노비페닐(TPD), N,N'-디페닐-N,N'-디나프틸-4,4'-디아미노비페닐, N,N,N'N'-테트라-p-톨릴-4,4'-디아미노비페닐, N,N,N'N'-테트라페닐-4,4'-디아미노비페닐, 코퍼(II)1,10,15,20-테트라페닐-21H,23H-포피린 등과 같은 포피린(porphyrin)화합물 유도체, 주쇄 또는 측쇄내에 방향족 3차아민을 갖는 중합체, 1,1-비스(4-디-p-톨릴아미노페닐)시클로헥산, N,N,N-트리(p-톨릴)아민, 4, 4', 4'-트리스[N-(3-메틸페닐)-N-페닐아미노]트리페닐아민과 같은 트리아릴아민 유도체, N-페닐카르바졸 및 폴리비닐카르바졸과 같은 카르바졸 유도체, 무금속 프탈로시아닌, 구리프탈로시아닌과 같은 프탈로시아닌 유도체, 스타버스트 아민 유도체, 엔아민스틸벤계 유도체, 방향족 삼급아민과 스티릴 아민 화합물의 유도체, 및 폴리실란 등을 들 수 있다.The hole transport layer or the hole injection layer of the present invention is a material commonly used as a hole transport material among photoconductive materials as a hole transport material and a hole injection material, and a known material used for the formation of a hole transport layer or a hole injection layer of an organic EL device. It may include. For example, N, N-dicarbazolyl-3,5-benzene (mCP), poly (3,4-ethylenedioxythiophene): polystyrenesulfonate (PEDOT: PSS), N, N'-di (1-naphthyl) -N, N '-diphenylbenzidine (NPD), N, N'-diphenyl-N, N'-di (3-methylphenyl) -4,4'-diaminobiphenyl (TPD), N, N'-diphenyl-N, N'-Dinaphthyl-4,4'-diaminobiphenyl, N, N, N'N'-tetra-p-tolyl-4,4'-diaminobiphenyl, N, N, N'N ' Porphyrin compound derivatives such as tetraphenyl-4,4'-diaminobiphenyl, copper (II) 1,10,15,20-tetraphenyl-21H, 23H-porphyrin, aromatic tertiary in the main chain or side chain Polymer with amine, 1,1-bis (4-di-p-tolylaminophenyl) cyclohexane, N, N, N-tri (p-tolyl) amine, 4, 4 ', 4'-tris [N- Triarylamine derivatives such as (3-methylphenyl) -N-phenylamino] triphenylamine, carbazole derivatives such as N-phenylcarbazole and polyvinylcarbazole, phthalocyanine derivatives such as metal-free phthalocyanine, copper phthalocyanine, starburst Amine May be a conductor, enamine stilbene derivatives, derivatives of aromatic tertiary amines and styrylamine compounds, polysilane and the like.

본 발명의 전자 수송층은 공지의 전자 수송 물질, 예를 들면 diphenylphosphine oxide-4-(triphenylsilyl)phenyl (TSPO1), Alq3, 2,5-디아릴 실롤 유도체(PyPySPyPy), 퍼플루오리네이티드 화합물(PF-6P), Octasubstituted cyclooctatetraene 화합물(COTs)을 포함할 수 있다.The electron transport layer of the present invention is a known electron transport material, for example diphenylphosphine oxide-4- (triphenylsilyl) phenyl (TSPO1), Alq 3 , 2,5-diaryl silol derivative (PyPySPyPy), perfluorinated compound (PF -6P), Octasubstituted cyclooctatetraene compounds (COTs).

본 발명의 유기전계 발광소자에 있어서, 전자 주입층, 전자 수송층, 정공 수송층 및 정공 주입층은 상기한 화합물의 하나 이상의 종류를 함유하는 단일 층으로 형성되거나, 또는 상호 적층된, 상이한 종류의 화합물을 함유하는 복수의 층으로 구성될 수 있다.In the organic light emitting device of the present invention, the electron injection layer, the electron transport layer, the hole transport layer and the hole injection layer may be formed of a single layer containing one or more kinds of the above-mentioned compounds, or may be stacked on different kinds of compounds. It may consist of a plurality of layers to contain.

본 발명의 유기전계 발광소자의 발광층은 공지된 발광재료, 예를 들면 축광 형광재료, 형광증백제, 레이저 색소, 유기 신틸레이터 및 형광 분석용 시약을 포함할 수 있다. 구체적으로는, 카바졸계 화합물, 포스핀옥사이드계 화합물, 카바졸계 포스핀옥사이드 화합물, bis((3,5-difluoro-4-cyanophenyl)pyridine) iridium picolinate(FCNIrpic), tris(8-hydroxyquinoline) aluminum(Alq3), 안트라센, 페난트렌, 피렌, 크리센, 페릴렌, 코로넨, 루브렌 및 퀴나크리돈과 같은 폴리아로마틱 화합물, 퀴터페닐과 같은 올리고페닐렌 화합물, 1,4-비스 (2-메틸스티릴)벤젠, 1,4-비스(4-메틸스티릴)벤젠, 1,4-비스(4-메틸-5-페닐-2-옥사졸릴)벤젠, 1,4-비스(5-페닐-2-옥사졸릴)벤젠, 2,5-비스(5-t-부틸-2-벤즈옥사졸릴)사이오펜, 1,4-디페닐-1,3-부타디엔, 1,6-디페닐-1,3,5-헥사트리엔,1,1,4,4-테트라페닐-1,3-부타디엔과 같은 액체신틸레이션용 신틸레이터, 옥신 유도체의 금속착체, 쿠마린 색소, 디시아노메틸렌피란 색소, 디시아노메틸렌사이오피란 색소, 폴리메틴 색소, 옥소벤즈안트라센 색소, 크산텐 색소, 카르보스티릴 색소, 페릴렌 색소, 옥사진 화합물, 스틸벤 유도체, 스피로 화합물, 옥사디아졸 화합물 등을 포함할 수 있다.The light emitting layer of the organic electroluminescent device of the present invention may include a known light emitting material, for example, a phosphorescent fluorescent material, a fluorescent brightener, a laser dye, an organic scintillator and a reagent for fluorescence analysis. Specifically, a carbazole compound, a phosphine oxide compound, a carbazole phosphine oxide compound, bis ((3,5-difluoro-4-cyanophenyl) pyridine) iridium picolinate (FCNIrpic), tris (8-hydroxyquinoline) aluminum ( Alq 3 ), polyaromatic compounds such as anthracene, phenanthrene, pyrene, chrysene, perylene, coronene, rubrene and quinacridone, oligophenylene compounds such as quiterphenyl, 1,4-bis (2-methyl Styryl) benzene, 1,4-bis (4-methylstyryl) benzene, 1,4-bis (4-methyl-5-phenyl-2-oxazolyl) benzene, 1,4-bis (5-phenyl- 2-oxazolyl) benzene, 2,5-bis (5-t-butyl-2-benzoxazolyl) thiophene, 1,4-diphenyl-1,3-butadiene, 1,6-diphenyl-1, Scintillators for liquid scintillation such as 3,5-hexatriene, 1,1,4,4-tetraphenyl-1,3-butadiene, metal complexes of auxin derivatives, coumarin pigments, dicyano methylene pyran pigments and dicyano methylene Thiopyran pigment, polymethine pigment, oxobenzanthracene Pigments, xanthene pigments, carbostyryl pigments, perylene pigments, oxazine compounds, stilbene derivatives, spiro compounds, oxadiazole compounds and the like.

본 발명의 유기 EL 소자를 구성하는 각 층은 진공 증착, 스핀 코팅 또는 캐스팅과 같은 공지된 방법을 통하여 박막으로 형성시키거나, 각 층에서 사용되는 재료를 이용하여 제조할 수 있다. 이들 각층의 막두께에 대해서는 특별한 제한은 없으며, 재료의 특성에 따라 알맞게 선택할 수 있으나, 보통 2nm 내지 5000nm의 범위에서 결정될 수 있다.Each layer constituting the organic EL device of the present invention can be formed into a thin film through a known method such as vacuum deposition, spin coating or casting, or can be produced using a material used in each layer. There is no particular limitation on the film thickness of each layer, and it can be appropriately selected depending on the properties of the material, but can usually be determined in the range of 2 nm to 5000 nm.

본 발명의 따른 화학식 1의 화합물은 진공 증착법에 의하여 형성될 수 있으므로, 박막 형성 공정이 간편하고, 핀홀(pin hole)이 거의 없는 균질한 박막으로 용이하게 얻을 수 있는 장점이 있다. Since the compound of Chemical Formula 1 according to the present invention may be formed by a vacuum deposition method, the thin film forming process is simple and has an advantage of being easily obtained as a homogeneous thin film having little pin holes.

이하, 실시예를 통하여 본 발명에 따른 스파이로 화합물 및 이를 포함하는 유기전계 발광소자의 제조방법을 더욱 구체적으로 설명한다. 그러나 이는 예시를 위한 것으로서 이에 의하여 본 발명의 범위가 한정되는 것이 아니다.Hereinafter, a spiro compound and a method of manufacturing an organic light emitting device including the same according to the present invention will be described in more detail with reference to Examples. However, this is for illustrative purposes and the scope of the present invention is not limited thereby.

[실시예][Example]

본 발명에 따르면, 먼저 본 발명의 스파이로 화합물을 제조하였고, 이 화합물을 사용하여 유기전계 발광소자를 제조하였다. 하기 제조예 및 실시예는 본 발명을 구체적으로 예시하기 위한 것으로, 이로써 본 발명이 제한되어서는 안 된다.According to the present invention, a spy compound of the present invention was first prepared, and an organic light emitting device was manufactured using the compound. The following Preparation Examples and Examples are intended to specifically illustrate the present invention, whereby the present invention should not be limited.

제조예Manufacturing example 1. 중간체 2,2'- 1.Intermediate 2,2'- 다이브로모바이페닐Dibromo biphenyl 화합물의 합성 Synthesis of compounds

1,2-다이브로모벤젠 10g을 테트라하이드로퓨란 100ml에 녹인 후 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 8.8ml를 천천히 적가 시켜주었다. 천천히 상온으로 올려주었다. 증류수를 부어 반응을 종결시키고 다이클로로메탄으로 추출하여 용매를 건조하였다. 반응물을 핵산으로 재결정으로 정제하여 중간체 2,2'-다이브로모바이페닐 화합물을 얻을 수 있었다. 10 g of 1,2-dibromobenzene was dissolved in 100 ml of tetrahydrofuran and the temperature was made to -78 ° C. Thereafter, 8.8 ml of butyllithium was slowly added dropwise. Slowly raised to room temperature. The reaction was terminated by distilled water and extracted with dichloromethane to dry the solvent. The reaction was purified by recrystallization from nucleic acid to afford the intermediate 2,2'-dibromobiphenyl compound.

제조예Manufacturing example 2. 중간체(1)의 합성 2. Synthesis of Intermediate (1)

2,2'-다이브로모바이페닐 2g을 테트라하이드로퓨란 15ml에 녹인 후 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 5.6ml를 천천히 적가 시켜주었다. 그대로 2시간동안 교반하고 35ml 테트라하이드로퓨란에 녹인 3.6g 2-브로모-9H-플루오레논을 천천히 적가하였다. 천천히 상온으로 올려주었다. 2% 탄산수소나트륨 수용액을 50ml를 넣어 교반해주었다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 황산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 화합물 중간체(1)을 얻을 수 있었다.2 g of 2,2'-dibromobiphenyl was dissolved in 15 ml of tetrahydrofuran and the temperature was made to -78 ° C. Thereafter, 5.6 ml of butyllithium was slowly added dropwise. The mixture was stirred for 2 hours as it was and 3.6 g 2-bromo-9H-fluorenone dissolved in 35 ml tetrahydrofuran was slowly added dropwise. Slowly raised to room temperature. 50 ml of 2% aqueous sodium hydrogen carbonate solution was added to the solution and stirred. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of sulfuric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. This solid was filtered and the compound intermediate (1) was obtained.

제조예 3. 화합물 1의 합성Preparation Example 3 Synthesis of Compound 1

Figure pat00259
Figure pat00259

화합물 중간체(1) 1.4g, 다이페닐아민0.93g, 팔라듐 아세테이트(2) 0.029g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 0.52g과 터트-포스핀 2.20g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 1을 얻을 수 있었다. 합성한 화합물 1은 유리전이온도가 142℃로 높은 값을 보였다.     1.4 g of compound intermediate (1), 0.93 g of diphenylamine, and 0.029 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 0.52 g of 1 mol solution sodium-tert-butoxide and 2.20 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. The solid was filtered to obtain Compound 1 as a pale yellow powder. Compound 1 showed a high glass transition temperature of 142 ℃.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.75(d, 2H), 7.50(d, 2H), 7.35-7.16(m, 22H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H)NMR-1H (200 MHz, CDCl3): δ 7.75 (d, 2H), 7.50 (d, 2H), 7.35-7.16 (m, 22H), 6.81 (t, 4H), 6.63 (m, 8H), 6.55 (s, 2H), 6.39 (d, 2H)

MS (FAB) m/z 814 [(M + 1)+].MS (FAB) m / z 814 [(M + 1) + ].

제조예 4. 화합물 2의 합성Preparation Example 4 Synthesis of Compound 2

Figure pat00260
Figure pat00260

화합물 중간체(1) 1.4g에 테트라하이드로퓨란 30ml을 넣고 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 2.19ml를 천천히 적가 하였다. 온도를 유지시키며 2시간동안 교반후에 클로로다이페닐포스핀 1.2g을 천천히 적가하고 상온으로 올려주었다. 반응 종결 후에 메탄올을 10ml을 넣고 교반하였고, 추출 후에 용매를 건조하였다. 이 고체에 다이클로로메탄을 넣고 교반하면서 소량의 과산화수소를 넣어 흰색의 포스핀산화물인 상기 대표예 화합물 구조를 갖는 화합물 2를 얻을 수 있었다. 합성한 화합물 2는 유리전이온도가 156℃로 높은 값을 보였다. 30 g of tetrahydrofuran was added to 1.4 g of the compound intermediate (1) to make the temperature at -78 ° C. Thereafter, 2.19 ml of butyllithium was slowly added dropwise. After stirring for 2 hours while maintaining the temperature, 1.2 g of chlorodiphenylphosphine was slowly added dropwise and raised to room temperature. After completion of the reaction, 10 ml of methanol was added thereto and stirred, and after extraction, the solvent was dried. Dichloromethane was added to this solid, and a small amount of hydrogen peroxide was added, stirring, and the compound 2 which has the above-mentioned typical compound structure of white phosphine oxide was obtained. Compound 2 showed a high glass transition temperature of 156 ℃.

핵자기 공명분석과 질량 분석을 하여 얻은 분석자료는 다음과 같다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H (200Hz, CDCl3) : 7.77-7.75(m, 12H), 7.45(m, 12H), 7.27(d, 4H), 7.16-7.14(m, 6H), 6.98-6.95(m, 6H)NMR-1H (200 Hz, CDCl3): 7.77-7.75 (m, 12H), 7.45 (m, 12H), 7.27 (d, 4H), 7.16-7.14 (m, 6H), 6.98-6.95 (m, 6H)

MS (FAB) m/z 878[(M+1)+].MS (FAB) m / z 878 [(M + l) + ].

제조예 5. 화합물 6의 합성Preparation Example 5 Synthesis of Compound 6

Figure pat00261
Figure pat00261

화합물 중간체(1) 1.4g, 다이페닐아민0.46g, 팔라듐 아세테이트(2) 0.015g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 0.26g과 터트-포스핀 1.10g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 테트라하이드로퓨란 30ml에 다 녹인 후 온도를 -78℃로 낮춘다. 부틸리튬 1.5ml를 천천히 적가해주고 2시간 동안 온도를 유지시키며 교반하였다. 클로로다이페닐포스핀 0.5g을 천천히 적가하고 온도를 상온으로 올려주었다. 반응 종결 후에 메탄올 10ml 넣고 교반하였고, 추출 후에 용매를 건조하였다. 이 고체에 다이클로로메탄을 넣고 교반하면서 소량의 과산화수소를 넣어 흰색 포스핀산화물인 화합물 6을 얻을 수 있었다. 1.4 g of compound intermediate (1), 0.46 g of diphenylamine, and 0.015 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 0.26 g of 1 mol solution sodium-tert-butoxide and 1.10 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid is dissolved in 30 ml of tetrahydrofuran and the temperature is lowered to -78 ° C. 1.5 ml of butyllithium was slowly added dropwise and stirred while maintaining the temperature for 2 hours. 0.5 g of chlorodiphenylphosphine was slowly added dropwise and the temperature was raised to room temperature. After completion of the reaction, 10 ml of methanol was added to the mixture, followed by stirring. After extraction, the solvent was dried. Dichloromethane was added to this solid, and a small amount of hydrogen peroxide was added while stirring to obtain compound 6 which is a white phosphine oxide.

합성한 화합물 6은 유리전이온도가 150℃로 높은 값을 보였다.Compound 6 synthesized showed a high glass transition temperature of 150 ℃.

핵자기 공명분석과 질량 분석을 하여 얻은 분석자료는 다음과 같다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H (200Hz, CDCl3) : 7.77-7.75(m, 7H), 7.50-7.35(m, 10H), 7.20-7.14(m, 12H), 6.98-6.95(m, 3H), 6.81(m, 2H), 6.63-6.55(m, 5H), 6.39(d, 1H)NMR-1H (200 Hz, CDCl3): 7.77-7.75 (m, 7H), 7.50-7.35 (m, 10H), 7.20-7.14 (m, 12H), 6.98-6.95 (m, 3H), 6.81 (m, 2H ), 6.63-6.55 (m, 5H), 6.39 (d, 1H)

MS (FAB) m/z 845 [(M+1)+].MS (FAB) m / z 845 [(M + l) + ].

제조예 6. 중간체4-브로모-9,9'-스파이로바이[플루오렌]의 합성Preparation Example 6 Synthesis of Intermediate 4-Bromo-9,9'-Spirobi [Fluorene]

2,2'-다이브로모바이페닐 3g을 테트라하이드로퓨란 15ml에 다 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.61ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 25ml에 9H-플루오레논 2g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 40ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 염산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 4-브로모-9,9'-스파이로바이[플루오렌]을 얻을 수 있었다. After 3 g of 2,2'-dibromobiphenyl was dissolved in 15 ml of tetrahydrofuran, the temperature was set to -78 ° C. 4.61 ml of butyllithium was slowly added dropwise and stirred for 2 hours. 2 g of 9H-fluorenone was dissolved in 25 ml of tetrahydrofuran, and slowly added dropwise thereto, and the temperature was raised to room temperature. After the reaction, 40 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate 4-bromo-9,9'-spirobi [fluorene].

제조예 7. 중간체(2)의 합성Preparation Example 7 Synthesis of Intermediate (2)

4-브로모-9,9'-스파이로바이[플루오렌] 5.7g을 테트라하이드로퓨란 76ml에 녹인 후 온도를 -78℃로 하였다. 부틸리튬 7.4ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 123ml에 2,7-다이브로모-플루오레논 6.3g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 200ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 100ml넣고 온도를 올려 다 녹여준다. 염산을 10ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 화합물 중간체(2)를 얻을 수 있었다.After dissolving 5.7 g of 4-bromo-9,9'-spirobi [fluorene] in 76 ml of tetrahydrofuran, the temperature was set to -78 ° C. 7.4 ml of butyllithium was slowly added dropwise and stirred for 2 hours. After dissolving 6.3 g of 2,7-dibromo-fluorenone in 123 ml of tetrahydrofuran, the mixture was slowly added dropwise and the temperature was raised to room temperature. After the reaction, 200 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 100 ml of acetic acid is added to this solid and the temperature is dissolved. 10 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. This solid was filtered and the compound intermediate (2) could be obtained.

제조예Manufacturing example 8. 화합물 3의 합성 8. Synthesis of Compound 3

Figure pat00262
Figure pat00262

화합물 중간체(2) 1g, 다이페닐아민 0.66g, 팔라듐 아세테이트(2) 0.021g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 0.37g과 터트-포스핀 0.3g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 4를 얻을 수 있었다.1 g of compound intermediate (2), 0.66 g of diphenylamine, and 0.021 g of palladium acetate (2) are added and dissolved in 30 ml of toluene. When the reagents were dissolved, 0.37 g of 1 mol solution sodium-tert-butoxide and 0.3 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. The solid was filtered to obtain Compound 4 as a pale yellow powder.

합성한 화합물 3은 유리전이온도가 140℃로 높은 값을 보였다.Compound 3 synthesized showed a high glass transition temperature of 140 ℃.

핵자기 공명분석과 질량 분석을 하여 얻은 분석자료는 다음과 같다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H (200Hz, CDCl3) : 7.75(d, 2H), 7.50(d, 2H), 7.36-7.35(m, 4H), 7.20-7.16(m, 16H), 6.81(m, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H)NMR-1H (200 Hz, CDCl3): 7.75 (d, 2H), 7.50 (d, 2H), 7.36-7.35 (m, 4H), 7.20-7.16 (m, 16H), 6.81 (m, 4H), 6.63 ( m, 8H), 6.55 (s, 2H), 6.39 (d, 2H)

MS (FAB) m/z 814 [(M+1)+].
MS (FAB) m / z 814 [(M + l) + ].

제조예Manufacturing example 9. 화합물 4의 합성 9. Synthesis of Compound 4

Figure pat00263
Figure pat00263

화합물 중간체(2) 1.5g에 테트라하이드로퓨란 30ml을 넣고 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 2.35ml를 천천히 적가 하였다. 온도를 유지시키며 2시간동안 교반후에 클로로다이페닐포스핀 1.3g을 천천히 적가하고 상온으로 올려주었다. 반응 종결 후에 메탄올을 10ml을 넣고 교반하였고, 추출 후에 용매를 건조하였다. 이 고체에 다이클로로메탄을 넣고 교반하면서 소량의 과산화수소를 넣어 흰색의 포스핀산화물인 상기 대표예 화합물 구조를 갖는 화합물 4를 얻을 수 있었다. 30 g of tetrahydrofuran was added to 1.5 g of the compound intermediate (2) to make the temperature at -78 ° C. Thereafter, 2.35 ml of butyllithium was slowly added dropwise. After stirring for 2 hours while maintaining the temperature, 1.3 g of chlorodiphenylphosphine was slowly added dropwise and raised to room temperature. After completion of the reaction, 10 ml of methanol was added thereto and stirred, and after extraction, the solvent was dried. Dichloromethane was added to this solid, and a small amount of hydrogen peroxide was added, and the compound 4 which has the above-mentioned typical compound structure of white phosphine oxide was obtained.

합성한 화합물 4는 유리전이온도가 151℃로 높은 값을 보였다.Compound 4 showed a high glass transition temperature of 151 ℃.

핵자기 공명분석과 질량 분석을 하여 얻은 분석자료는 다음과 같다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H (200Hz, CDCl3) : 7.77-7.75(m, 12H), 7.45(d, 12H), 7.36-7.35(m, 4H), 7.19-7.14(m, 10H), 6.98(d, 2H)NMR-1H (200 Hz, CDCl3): 7.77-7.75 (m, 12H), 7.45 (d, 12H), 7.36-7.35 (m, 4H), 7.19-7.14 (m, 10H), 6.98 (d, 2H)

MS (FAB) m/z 878 [(M+1)+].MS (FAB) m / z 878 [(M + l) + ].

제조예Manufacturing example 10. 화합물 5의 합성 10. Synthesis of Compound 5

Figure pat00264
Figure pat00264

화합물 중간체(2) 1.4g, 다이페닐아민0.46g, 팔라듐 아세테이트(2) 0.015g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 0.26g과 터트-포스핀 1.10g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 테트라하이드로퓨란 30ml에 다 녹인 후 온도를 -78℃로 낮춘다. 부틸리튬 1.5ml를 천천히 적가해주고 2시간동안 온도를 유지시키며 교반하였다. 클로로다이페닐포스핀 0.5g을 천천히 적가하고 온도를 상온으로 올려주었다. 반응 종결 후에 메탄올 10ml 넣고 교반하였고, 추출 후에 용매를 건조하였다. 이 고체에 다이클로로메탄을 넣고 교반하면서 소량의 과산화수소를 넣어 흰색 포스핀산화물인 화합물 5를 얻을 수 있었다. 1.4 g of compound intermediate (2), 0.46 g of diphenylamine, and 0.015 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 0.26 g of 1 mol solution sodium-tert-butoxide and 1.10 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid is dissolved in 30 ml of tetrahydrofuran and the temperature is lowered to -78 ° C. 1.5 ml of butyllithium was slowly added dropwise and stirred while maintaining the temperature for 2 hours. 0.5 g of chlorodiphenylphosphine was slowly added dropwise and the temperature was raised to room temperature. After completion of the reaction, 10 ml of methanol was added to the mixture, followed by stirring. After extraction, the solvent was dried. Dichloromethane was added to this solid, and a small amount of hydrogen peroxide was added while stirring to obtain compound 5 which is a white phosphine oxide.

합성한 화합물 5는 유리전이온도가 147℃로 높은 값을 보였다.Compound 5 showed a high glass transition temperature of 147 ℃.

핵자기 공명분석과 질량 분석을 하여 얻은 분석자료는 다음과 같다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H (200Hz, CDCl3) : 7.77-7.75(m, 7H), 7.50-7.45(m, 7H), 7.36-7.35(m, 4H), 7.20-7.14(m, 13H), 6.98(d, 2H), 6.81(t, 2H), 6.63(m, 4H), 6.34(s, 1H), 6.18(d, 1H)NMR-1H (200 Hz, CDCl3): 7.77-7.75 (m, 7H), 7.50-7.45 (m, 7H), 7.36-7.35 (m, 4H), 7.20-7.14 (m, 13H), 6.98 (d, 2H) ), 6.81 (t, 2H), 6.63 (m, 4H), 6.34 (s, 1H), 6.18 (d, 1H)

MS (FAB) m/z 845 [(M+1)+].MS (FAB) m / z 845 [(M + l) + ].

제조예Manufacturing example 11. 중간체 2,2'- 11.Intermediate 2,2'- 다이브로모Dibromo -4,4'--4,4'- 다이메틸바이페닐의Dimethylbiphenyl 합성 synthesis

1,2-다이브로모-4-메틸벤젠 10g을 100ml의 테트라하이드라퓨란에 다 녹여주었다. 온도를 -78℃로 낮추어 주고 부틸리튬 9ml를 천천히 적가하면서 교반하였다. 10 g of 1,2-dibromo-4-methylbenzene was dissolved in 100 ml of tetrahydrofuran. The temperature was lowered to −78 ° C. and 9 ml of butyllithium was slowly added dropwise and stirred.

온도를 상온으로 천천히 올려주었다. 다이클로로메탄과 순수로 추출을 하였다. 용매를 건조시킨 후 핵산으로 재결정을 시도하여 결정상태의 중간체 2,2'-다이브로모-4,4'-다이메틸바이페닐 화합물을 얻었다. The temperature was slowly raised to room temperature. Extraction was performed with dichloromethane and pure water. The solvent was dried and then recrystallized with nucleic acid to obtain an intermediate 2,2'-dibromo-4,4'-dimethylbiphenyl compound in a crystalline state.

제조예Manufacturing example 12. 중간체(3)의 합성 12. Synthesis of Intermediate (3)

2,2'-다이브로모-4,4'-다이메틸바이페닐 2g을 테트라하이드로퓨란을 15ml에 녹인 후 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 5.6ml를 천천히 적가 시켜주었다. 그대로 2시간동안 교반하고 35ml 테트라하이드로퓨란에 녹인 3.6g 2-브로모-9H-플루오레논을 천천히 적가하였다. 천천히 상온으로 올려주었다. 2% 탄산수소나트륨 수용액을 50ml를 넣어 교반해주었다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 황산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 화합물 중간체(3)을 얻을 수 있었다.2 g of 2,2'-dibromo-4,4'-dimethylbiphenyl was dissolved in 15 ml of tetrahydrofuran and the temperature was made to -78 ° C. Thereafter, 5.6 ml of butyllithium was slowly added dropwise. The mixture was stirred for 2 hours as it was and 3.6 g 2-bromo-9H-fluorenone dissolved in 35 ml tetrahydrofuran was slowly added dropwise. Slowly raised to room temperature. 50 ml of 2% aqueous sodium hydrogen carbonate solution was added to the solution and stirred. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of sulfuric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the compound intermediate (3).

제조예Manufacturing example 11. 화합물 100의 합성 11.Synthesis of Compound 100

Figure pat00265
Figure pat00265

화합물 중간체(3) 2g, 다이페닐아민 1.9g, 팔라듐 아세테이트(2) 0.064g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.3g과 터트-포스핀 4.8g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 100을 얻을 수 있었다. 2 g of compound intermediate (3), 1.9 g of diphenylamine, and 0.064 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.3 g of 1 mol solution sodium-tert-butoxide and 4.8 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. The solid was filtrated to obtain Compound 100 as a pale yellow powder.

유리전이온도는 관찰되지 않았다. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.75(d, 2H), 7.50(d, 2H), 7.35(d, 2H), 7.20-7.16(m, 12H), 7.07(s, 4H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H), 2.34(s, 6H)NMR-1H (200 MHz, CDCl3): δ 7.75 (d, 2H), 7.50 (d, 2H), 7.35 (d, 2H), 7.20-7.16 (m, 12H), 7.07 (s, 4H), 6.81 (t, 4H), 6.63 (m, 8H), 6.55 (s, 2H), 6.39 (d, 2H), 2.34 (s, 6H)

MS (FAB) m/z 840 [(M + 1)+].MS (FAB) m / z 840 [(M + 1) + ].

제조예Manufacturing example 12. 중간체 4- 12. Intermediate 4- 브로모Bromo -2,7--2,7- 다이메틸Dimethyl -9,9'--9,9'- 스파이로바이[플루오렌]의Of spiroby [fluorene] 합성 synthesis

2,2'-다이브로모-4,4'-다이메틸바이페닐 3g을 테트라하이드로퓨란 15ml에 다 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.61ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 25ml에 9H-플루오레논 2g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 40ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 염산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 4-브로모-2,7-다이메틸-9,9'-스파이로바이[플루오렌]을 얻을 수 있었다.After 3 g of 2,2'-dibromo-4,4'-dimethylbiphenyl was dissolved in 15 ml of tetrahydrofuran, the temperature was set to -78 ° C. 4.61 ml of butyllithium was slowly added dropwise and stirred for 2 hours. 2 g of 9H-fluorenone was dissolved in 25 ml of tetrahydrofuran, and slowly added dropwise thereto, and the temperature was raised to room temperature. After the reaction, 40 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate 4-bromo-2,7-dimethyl-9,9'-spirobi [fluorene].

제조예13Production Example 13 . 중간체(4)의 합성. Synthesis of Intermediate (4)

4-브로모-2,7-다이메틸-9,9'-스파이로바이[플루오렌] 5.7g을 테트라하이드로퓨란 76ml에 녹인 후 온도를 -78℃로 하였다. 부틸리튬 7.4ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 123ml에 2,7-다이브로모-플루오레논 6.3g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 200ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 100ml넣고 온도를 올려 다 녹여준다. 염산을 10ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 화합물 중간체(4)를 얻을 수 있었다.After dissolving 5.7 g of 4-bromo-2,7-dimethyl-9,9'-spirobi [fluorene] in 76 ml of tetrahydrofuran, the temperature was set to -78 ° C. 7.4 ml of butyllithium was slowly added dropwise and stirred for 2 hours. After dissolving 6.3 g of 2,7-dibromo-fluorenone in 123 ml of tetrahydrofuran, the mixture was slowly added dropwise and the temperature was raised to room temperature. After the reaction, 200 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 100 ml of acetic acid is added to this solid and the temperature is dissolved. 10 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. This solid was filtered and the compound intermediate (4) was obtained.

제조예 14. 화합물 117의 합성Preparation Example 14 Synthesis of Compound 117

Figure pat00266
Figure pat00266

화합물 중간체(4) 2g, 다이페닐아민 1.9g, 팔라듐 아세테이트(2) 0.064g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.3g과 터트-포스핀 4.8g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 117을 얻을 수 있었다. 2 g of compound intermediate (4), 1.9 g of diphenylamine, and 0.064 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.3 g of 1 mol solution sodium-tert-butoxide and 4.8 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid was filtrated to give Compound 117 as a pale yellow powder.

유리전이온도는 관찰되지 않았다.No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.75 (d, 2H), 7.50(d, 2H), 7.35(d, 2H), 7.20-7.16(m, 14H), 6.98(s, 2H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H), 2.34(s, 6H) NMR-1H (200 MHz, CDCl3): δ7.75 (d, 2H), 7.50 (d, 2H), 7.35 (d, 2H), 7.20-7.16 (m, 14H), 6.98 (s, 2H), 6.81 (t, 4H), 6.63 (m, 8H), 6.55 (s, 2H), 6.39 (d, 2H), 2.34 (s, 6H)

MS (FAB) m/z 840 [(M + 1)+].MS (FAB) m / z 840 [(M + 1) + ].

제조예 15.중간체 2,7-다이페닐-9H-플루오레논의 합성Preparation Example 15 Synthesis of Intermediate 2,7-Diphenyl-9H-Fluorenone

2,7-다이브로모-9H-플루오렌-9-온 2g, 페닐보로닉 액시드 1.5g, 테트라키스(페닐포스핀)팔라듐(0) 0.68g를 테트라하이드로퓨란 30ml에 다 녹여 주었다. 2 몰 탄산칼륨 수용액 30ml를 반응기에 넣고 온도를 120℃로 유지하며 환류시켜 주었다. 반응 끝난 후 다이클로로메탄으로 추출해준 후 용매를 건조하였다. 이 고체를 여과하여 중간체 2,7-다이페닐-9H-플루오레논 화합물을 얻었다. 2 g of 2,7-dibromo-9H-fluorene-9-one, 1.5 g of phenylboronic acid, and 0.68 g of tetrakis (phenylphosphine) palladium (0) were dissolved in 30 ml of tetrahydrofuran. 30 ml of a 2 mol potassium carbonate aqueous solution was put in a reactor and refluxed while maintaining the temperature at 120 ° C. After the reaction was extracted with dichloromethane and the solvent was dried. This solid was filtered to obtain an intermediate 2,7-diphenyl-9H-fluorenone compound.

제조예 16. 중간체 4-브로모-2',7'-다이페닐-9,9'-스파이로바이[플루오렌]의 합성Preparation Example 16 Synthesis of Intermediate 4-Bromo-2 ', 7'-diphenyl-9,9'-spirobi [fluorene]

2,2'-다이브로모바이페닐 3g을 테트라하이드로퓨란 15ml에 다 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.61ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 25ml에 2,7-다이페닐-9H-플루오레논 2g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 40ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 염산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 4-브로모-2',7'-다이페닐-9,9'-스파이로바이[플루오렌]을 얻을 수 있었다. After 3 g of 2,2'-dibromobiphenyl was dissolved in 15 ml of tetrahydrofuran, the temperature was set to -78 ° C. 4.61 ml of butyllithium was slowly added dropwise and stirred for 2 hours. 2 g of 2,7-diphenyl-9H-fluorenone was dissolved in 25 ml of tetrahydrofuran, and slowly added dropwise thereto, and the temperature was raised to room temperature. After the reaction, 40 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate 4-bromo-2 ', 7'-diphenyl-9,9'-spirobi [fluorene].

제조예 17.중간체(5)의 합성Preparation Example 17 Synthesis of Intermediate (5)

4-브로모-2',7'-다이페닐-9,9'-스파이로바이[플루오렌] 5.7g을 테트라하이드로퓨란 76ml에 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.9ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 123ml에 2,7-다이브로모-플루오레논 4.2g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 200ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 100ml넣고 온도를 올려 다 녹여준다. 염산을 10ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체(5)를 얻을 수 있었다.5.7 g of 4-bromo-2 ', 7'-diphenyl-9,9'-spirobi [fluorene] was dissolved in 76 ml of tetrahydrofuran and the temperature was set to -78 deg. 4.9 ml of butyllithium were slowly added dropwise and stirred for 2 hours. After dissolving 4.2 g of 2,7-dibromo-fluorenone in 123 ml of tetrahydrofuran, the mixture was slowly added dropwise and the temperature was raised to room temperature. After the reaction, 200 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 100 ml of acetic acid is added to this solid and the temperature is dissolved. 10 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate (5).

제조예 18. 화합물 66의 합성Preparation Example 18 Synthesis of Compound 66

Figure pat00267
Figure pat00267

화합물 중간체(5) 2g, 다이페닐아민 2.1g, 팔라듐 아세테이트(2) 0.075g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.9g과 터트-포스핀 6.5g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 66을 얻을 수 있었다.   2 g of compound intermediate (5), 2.1 g of diphenylamine, and 0.075 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.9 g of 1 mol solution sodium-tert-butoxide and 6.5 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid was filtered to give Compound 66 as a pale yellow powder.

유리전이온도는 관찰되지 않았다. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.81 (d, 2H), 7.57-7.36 (m, 18H), 7.20-7.16(m, 12H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H)NMR-1H (200 MHz, CDCl3): δ 7.81 (d, 2H), 7.57-7.36 (m, 18H), 7.20-7.16 (m, 12H), 6.81 (t, 4H), 6.63 (m, 8H) , 6.55 (s, 2H), 6.39 (d, 2H)

MS (FAB) m/z 964 [(M + 1)+].MS (FAB) m / z 964 [(M + 1) + ].

제조예 19. 중간체 2,7-다이메틸-플루오레논의 합성Preparation Example 19 Synthesis of Intermediate 2,7-Dimethyl-Fluorenone

2,7'-다이브로모-9H-플루오레논 2g, 브로모메탄 1.2g, 알루미늄 트리클로라이드 0.03g을 아세트로나이트릴 30ml에 다 녹여 주었다. 온도를 100℃로 유지시켜주며 환류시켜주었다. 다이클로로메탄으로 여과 정제하여 중간체 2,7-다이메틸-플루오레논 화합물을 얻었다. 2 g of 2,7'-dibromo-9H-fluorenone, 1.2 g of bromomethane, and 0.03 g of aluminum trichloride were dissolved in 30 ml of acetonitrile. The temperature was maintained at 100 ° C. and refluxed. Filtration and purification with dichloromethane gave the intermediate 2,7-dimethyl-fluorenone compound.

제조예 20. 중간체 4-브로모-2',7'-다이메틸-9,9'-스파이로바이[플루오렌]의 합성Preparation Example 20 Synthesis of Intermediate 4-Bromo-2 ', 7'-dimethyl-9,9'-spirobi [fluorene]

2,2'-다이브로모바이페닐 3g을 테트라하이드로퓨란 15ml에 다 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.61ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 25ml에 2,7-다이메틸-9H-플루오레논 2g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 40ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 염산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 4-브로모-2',7'-다이메틸-9,9'-스파이로바이[플루오렌]을 얻을 수 있었다. After 3 g of 2,2'-dibromobiphenyl was dissolved in 15 ml of tetrahydrofuran, the temperature was set to -78 ° C. 4.61 ml of butyllithium was slowly added dropwise and stirred for 2 hours. 2 g of 2,7-dimethyl-9H-fluorenone was dissolved in 25 ml of tetrahydrofuran, and slowly added dropwise thereto, and the temperature was raised to room temperature. After the reaction, 40 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain intermediate 4-bromo-2 ', 7'-dimethyl-9,9'-spirobi [fluorene].

제조예 21. 중간체(6)의 합성Preparation Example 21 Synthesis of Intermediate (6)

4-브로모-2',7'-다이메틸-9,9'-스파이로바이[플루오렌] 5.7g을 테트라하이드로퓨란 76ml에 녹인 후 온도를 -78℃로 하였다. 부틸리튬 7.4ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 123ml에 2,7-다이브로모-플루오레논 6.3g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 200ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 100ml넣고 온도를 올려 다 녹여준다. 염산을 10ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체(6)을 얻을 수 있었다.5.7 g of 4-bromo-2 ', 7'-dimethyl-9,9'-spirobi [fluorene] was dissolved in 76 ml of tetrahydrofuran and the temperature was set to -78 deg. 7.4 ml of butyllithium was slowly added dropwise and stirred for 2 hours. After dissolving 6.3 g of 2,7-dibromo-fluorenone in 123 ml of tetrahydrofuran, the mixture was slowly added dropwise and the temperature was raised to room temperature. After the reaction, 200 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 100 ml of acetic acid is added to this solid and the temperature is dissolved. 10 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. This solid was filtered and obtained to obtain the intermediate (6).

제조예 22. 화합물 49의 합성Preparation Example 22 Synthesis of Compound 49

Figure pat00268
Figure pat00268

화합물 중간체(6) 2g, 다이페닐아민 1.9g, 팔라듐 아세테이트(2) 0.064g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.3g과 터트-포스핀 4.8g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 49을 얻을 수 있었다. 2 g of compound intermediate (6), 1.9 g of diphenylamine and 0.064 g of palladium acetate (2) were added, and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.3 g of 1 mol solution sodium-tert-butoxide and 4.8 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. The solid was filtered and purified to obtain Compound 49 as a pale yellow powder.

유리전이온도는 관찰되지 않았다. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.63 (d, 2H), 7.50 (d, 2H), 7.36(d, 2H), 7.20-7.15(m, 14H), 6.99(d, 2H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H), 2.34(s, 6H) NMR-1H (200 MHz, CDCl3): δ7.63 (d, 2H), 7.50 (d, 2H), 7.36 (d, 2H), 7.20-7.15 (m, 14H), 6.99 (d, 2H), 6.81 (t, 4H), 6.63 (m, 8H), 6.55 (s, 2H), 6.39 (d, 2H), 2.34 (s, 6H)

MS (FAB) m/z 840 [(M + 1)+].MS (FAB) m / z 840 [(M + 1) + ].

제조예 23. 중간체 3,4-다이브로모페닐의 합성Preparation Example 23 Synthesis of Intermediate 3,4-Dibromophenyl

1,2,4-트리브로모벤젠 2g, 페닐보로닉 액시드 0.92g, 테트라키스(페닐포스핀)팔라듐(0) 0.36g를 테트라하이드로퓨란 30ml에 다 녹여 주었다. 2 몰 탄산칼륨 수용액 30ml를 반응기에 넣고 온도를 120℃로 유지하며 환류시켜 주었다. 반응 끝난 후 다이클로로메탄으로 추출해준 후 용매를 건조하였다. 이 고체를 여과하여 중간체 3,4-다이브로모페닐 화합물을 얻었다. 2 g of 1,2,4-tribromobenzene, 0.92 g of phenylboronic acid, and 0.36 g of tetrakis (phenylphosphine) palladium (0) were dissolved in 30 ml of tetrahydrofuran. 30 ml of a 2 mol potassium carbonate aqueous solution was put in a reactor and refluxed while maintaining the temperature at 120 ° C. After the reaction was extracted with dichloromethane and the solvent was dried. This solid was filtered to give the intermediate 3,4-dibromophenyl compound.

제조예 24. 중간체 2'',3'-다이브로모-파라-쿼터페닐의 합성Preparation Example 24 Synthesis of Intermediate 2 '', 3'-Dibromo-Para-Quarterphenyl

3,4-다이브로모페닐 10g을 100ml의 테트라하이드라퓨란에 다 녹여주었다. 온도를 -78℃로 낮추어 주고 부틸리튬 6.6ml를 천천히 적가하면서 교반하였다. 10 g of 3,4-dibromophenyl was dissolved in 100 ml of tetrahydrofuran. The temperature was lowered to -78 ° C and 6.6 ml of butyllithium was slowly added dropwise and stirred.

온도를 상온으로 천천히 올려주었다. 다이클로로메탄과 순수로 추출을 하였다. 용매를 건조시킨 후 핵산으로 재결정을 시도하여 결정상태의 중간체 2'',3'-다이브로모-파라-쿼터페닐 화합물을 얻었다. The temperature was slowly raised to room temperature. Extraction was performed with dichloromethane and pure water. The solvent was dried and then recrystallized with nucleic acid to obtain an intermediate 2 '', 3'-dibromo-para-quaterphenyl compound in a crystalline state.

제조예Manufacturing example 25. 중간체(7)의 합성 25. Synthesis of Intermediate (7)

2'',3'-다이브로모-파라-쿼터페닐 2g을 테트라하이드로퓨란을 15ml에 녹인 후 온도를 -78℃로 만들어 주었다. 그 후에 부틸리튬 4.3ml를 천천히 적가 시켜주었다. 그대로 2시간동안 교반하고 35ml 테트라하이드로퓨란에 녹인 2.8g 2-브로모-9H-플루오레논을 천천히 적가하였다. 천천히 상온으로 올려주었다. 2% 탄산수소나트륨 수용액을 50ml를 넣어 교반해주었다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 황산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 화합물 중간체(7)을 얻을 수 있었다.2 g of 2 '', 3'-dibromo-para-quaterphenyl was dissolved in 15 ml of tetrahydrofuran and the temperature was made to -78 ° C. Thereafter, 4.3 ml of butyllithium was slowly added dropwise. After stirring for 2 hours, 2.8 g 2-bromo-9H-fluorenone dissolved in 35 ml tetrahydrofuran was slowly added dropwise. Slowly raised to room temperature. 50 ml of 2% aqueous sodium hydrogen carbonate solution was added to the solution and stirred. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of sulfuric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the compound intermediate (7).

제조예Manufacturing example 26. 화합물 83의 합성 26. Synthesis of Compound 83

Figure pat00269
Figure pat00269

화합물 중간체 7 2g, 다이페닐아민 2.1g, 팔라듐 아세테이트(2) 0.075g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.9g과 터트-포스핀 6.5g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 66을 얻을 수 있었다.2 g of compound intermediate 7, 2.1 g of diphenylamine, and 0.075 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.9 g of 1 mol solution sodium-tert-butoxide and 6.5 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid was filtered to give Compound 66 as a pale yellow powder.

유리전이온도는 관찰되지 않았다.No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

NMR-1H(200 MHz, CDCl3) : δ7.75 (d, 2H), 7.52-7.35 (m, 18H), 7.20-7.16(m, 12H), 6.81(t, 4H), 6.63(m, 8H), 6.55(s, 2H), 6.39(d, 2H) NMR-1H (200 MHz, CDCl3): δ7.75 (d, 2H), 7.52-7.35 (m, 18H), 7.20-7.16 (m, 12H), 6.81 (t, 4H), 6.63 (m, 8H) , 6.55 (s, 2H), 6.39 (d, 2H)

MS (FAB) m/z 964 [(M + 1)+].MS (FAB) m / z 964 [(M + 1) + ].

제조예Manufacturing example 27. 중간체 4- 27. Intermediate 4- 브로모Bromo -2,7--2,7- 다이페닐Diphenyl -9,9'--9,9'- 스파이로바이[플루오렌]의Of spiroby [fluorene] 합성 synthesis

2'',3'-다이브로모-파라-쿼터페닐 3g을 테트라하이드로퓨란 15ml에 다 녹인 후 온도를 -78℃로 하였다. 부틸리튬 3.1ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 25ml에 9H-플루오레논 1.39g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 40ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 50ml넣고 온도를 올려 다 녹여준다. 염산을 5ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 4-브로모-2,7-다이페닐-9,9'-스파이로바이[플루오렌]을 얻을 수 있었다. After dissolving 3 g of 2 '', 3'-dibromo-para-quaterphenyl in 15 ml of tetrahydrofuran, the temperature was set to -78 ° C. 3.1 ml of butyllithium were slowly added dropwise and stirred for 2 hours. 1.39 g of 9H-fluorenone was dissolved in 25 ml of tetrahydrofuran, and slowly added dropwise thereto, and the temperature was raised to room temperature. After the reaction, 40 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 50 ml of acetic acid is added to this solid and the temperature is dissolved. 5 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate 4-bromo-2,7-diphenyl-9,9'-spirobi [fluorene].

제조예Manufacturing example 28. 중간체(8)의 합성 28. Synthesis of Intermediate (8)

4-브로모-2,7-다이페닐-9,9'-스파이로바이[플루오렌] 5.7g을 테트라하이드로퓨란 76ml에 녹인 후 온도를 -78℃로 하였다. 부틸리튬 4.99ml를 천천히 적가하고 2시간동안 교반하였다. 테트라하이드로퓨란 123ml에 2,7-다이브로모-플루오레논 4.22g을 녹인 후 천천히 적가하고 온도를 상온으로 올려주었다. 반응이 끝난 후 2% 탄산수소나트륨 수용액 200ml를 넣어 교반해주었다. 다이클로로메탄으로 추출 후 용매를 건조하였다. 다이클로로메탄으로 추출하고 용매를 건조하였다. 이 고체에 아세트산 100ml넣고 온도를 올려 다 녹여준다. 염산을 10ml 넣고 온도를 120℃를 유지시키며 환류시켜 주었다. 반응이 끝난 후 다이클로로메탄과 증류수를 이용하여 추출 후 용매를 건조하였다. 이 고체를 여과 정제하여 중간체 화합물(8)을 얻을 수 있었다.After dissolving 5.7 g of 4-bromo-2,7-diphenyl-9,9'-spirobi [fluorene] in 76 ml of tetrahydrofuran, the temperature was set to -78 ° C. 4.99 ml of butyllithium was slowly added dropwise and stirred for 2 hours. After dissolving 4.22 g of 2,7-dibromo-fluorenone in 123 ml of tetrahydrofuran, the mixture was slowly added dropwise and the temperature was raised to room temperature. After the reaction, 200 ml of a 2% aqueous sodium hydrogen carbonate solution was added and stirred. After extraction with dichloromethane the solvent was dried. Extract with dichloromethane and dry the solvent. 100 ml of acetic acid is added to this solid and the temperature is dissolved. 10 ml of hydrochloric acid was added and refluxed at 120 ° C. After the reaction, the solvent was dried after extraction using dichloromethane and distilled water. The solid was filtered to obtain the intermediate compound (8).

제조예Manufacturing example 29. 화합물 127의 합성 29. Synthesis of Compound 127

Figure pat00270
Figure pat00270

화합물 중간체(8) 2g, 다이페닐아민 2.1g, 팔라듐 아세테이트(2) 0.075g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 1.9g과 터트-포스핀 6.5g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 127을 얻을 수 있었다. 유리전이온도는 관찰되지 않았다. 2 g of compound intermediate (8), 2.1 g of diphenylamine, and 0.075 g of palladium acetate (2) were added and dissolved in 30 ml of toluene. When the reagents were dissolved, 1.9 g of 1 mol solution sodium-tert-butoxide and 6.5 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid was filtered to give Compound 127 as a pale yellow powder. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

MR-1H(200 MHz, CDCl3) : δ7.75 (d, 2H), 7.58-7.35 (m, 18H), 7.20-7.16 (m, 12H), 6.81 (t, 4H), 6.63 (d, 8H), 6.55 (s, 2H), 6.39 (d, 2H) MR-1H (200 MHz, CDCl3): δ7.75 (d, 2H), 7.58-7.35 (m, 18H), 7.20-7.16 (m, 12H), 6.81 (t, 4H), 6.63 (d, 8H) , 6.55 (s, 2H), 6.39 (d, 2H)

MS (FAB) m/z 964 [(M + 1)+].MS (FAB) m / z 964 [(M + 1) + ].

제조예Manufacturing example 30. 화합물 137의 합성 30. Synthesis of Compound 137

Figure pat00271
Figure pat00271

화합물 중간체(1) 2g과 피리딘-3-일보로닉 액시드 0.84g, 테트라키스(페닐포스핀)팔라듐(0) 0.36g을 테트라하이드로퓨란 30ml에 다 녹인다. 2M 파타슘 카르보네이트 수용액 30ml를 적가 하고 온도를 120℃로 유지시키며 환류하였다. 반응액을 다이클로로메탄으로 추출하고 용매를 건조 후에 고체를 여과하여 화합물 137을 얻었다. 2 g of compound intermediate (1), 0.84 g of pyridin-3-ylboronic acid, and 0.36 g of tetrakis (phenylphosphine) palladium (0) are dissolved in 30 ml of tetrahydrofuran. 30 ml of 2M aqueous potassium carbonate solution was added dropwise and refluxed while maintaining the temperature at 120 ° C. The reaction solution was extracted with dichloromethane, the solvent was dried and the solid was filtered to give compound 137.

유리전이온도는 관찰되지 않았다. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

MR-1H(200 MHz, CDCl3) : δ 9.24 (s, 2H), 8.70 (d, 2H), 8.42 (d, 2H), 7.81-7.75 (m, 4H), 7.57 (t, 4H), 7.44 (d, 2H), 7.35-7.16 (m, 12H)MR-1H (200 MHz, CDCl3): δ 9.24 (s, 2H), 8.70 (d, 2H), 8.42 (d, 2H), 7.81-7.75 (m, 4H), 7.57 (t, 4H), 7.44 ( d, 2H), 7.35-7.16 (m, 12H)

MS (FAB) m/z 632 [(M + 1)+].MS (FAB) m / z 632 [(M + 1) + ].

제조예Manufacturing example 31. 화합물 149의 합성 31. Synthesis of Compound 149

Figure pat00272
Figure pat00272

화합물 중간체(1) 1g, 다이페닐아민 0.65g, 팔라듐 아세테이트(2) 0.02g을 넣고 톨루엔 30ml에 녹인다. 시약이 다 녹으면 1 몰 용액 소디움-터트-부톡사이드 0.3g과 터트-포스핀 0.31g을 적가하였다. 온도를 120℃를 유지시키며 환류시킨다. 반응이 끝난 후 다이클로로메탄과 증류수로 추출하여 용매를 건조한다. 이 고체를 여과 정제하여 옅은 노란색 파우더인 화합물 149를 얻을 수 있었다. Add 1 g of compound intermediate (1), 0.65 g of diphenylamine, and 0.02 g of palladium acetate (2), and dissolve in 30 ml of toluene. When the reagents were dissolved, 0.3 g of 1 mol solution sodium-tert-butoxide and 0.31 g of tert-phosphine were added dropwise. Reflux while maintaining the temperature at 120 ° C. After the reaction, the mixture is extracted with dichloromethane and distilled water to dry the solvent. This solid was filtered to give Compound 149 as a pale yellow powder.

유리전이온도는 관찰되지 않았다. No glass transition temperature was observed.

핵자기 공명분석과 질량분석을 하여 얻은 분석자료는 아래와 같았다.The analysis data obtained by nuclear magnetic resonance and mass spectrometry are as follows.

MR-1H(200 MHz, CDCl3) : δ 8.55 (d, 2H), 8.12 (d, 2H), 7.94 (d, 2H), 7.75 (d, 2H), 7.63 (d, 2H), 7.50 (t, 2H), 7.33-7.14 (m, 16H), 6.98-6.95 (m, 6H)MR-1H (200 MHz, CDCl3): δ 8.55 (d, 2H), 8.12 (d, 2H), 7.94 (d, 2H), 7.75 (d, 2H), 7.63 (d, 2H), 7.50 (t, 2H), 7.33-7.14 (m, 16H), 6.98-6.95 (m, 6H)

MS (FAB) m/z 808 [(M + 1)+].MS (FAB) m / z 808 [(M + 1) + ].

실시예Example 1 One

본 발명에서 합성한 화합물 1을 녹색 인광소자의 정공수송층 물질로서 적용하여 녹색인광소자를 제작하였다. Compound 1 synthesized in the present invention was applied as a hole transport layer material of the green phosphor to prepare a green phosphor.

소자의 구조는 ITO/DNTPD(N,N'-diphenyl-N,N'-bis-[4-(phenyl-m-tolyl-amino)-phenyl]-biphenyl-4,4'-diamine, 60nm)/화합물 1(30nm)/TMM004(Merck Co.):Ir(ppy)3(30nm, 10%)/Alq3(20nm)/LiF/Al이었다. The structure of the device is ITO / DNTPD (N, N'-diphenyl-N, N'-bis- [4- (phenyl-m-tolyl-amino) -phenyl] -biphenyl-4,4'-diamine, 60nm) / Compound 1 (30 nm) / TMM004 (Merck Co.): Ir (ppy) 3 (30 nm, 10%) / Alq 3 (20 nm) / LiF / Al.

소자의 제작은 다음과 같은 방법으로 수행하였다. ITO 기판은 순수와 이소프로필 알코올을 이용하여 초음파에서 30분간 세정한 후 ITO 기판을 단파장의 자외선을 이용하여 표면처리한 후 1x10-6 torr의 압력하에서 유기물을 진공 증착하였다. DNTPD, 화합물 1, Alq3은 0.1 nm/s의 속도로 증착하여 각 두께에 해당하는 막을 형성하였고, PH1은 Ir(ppy)3 도펀트와 진공증착하였으며, 이때 증착속도는 PH1은 0.1 nm/s, Ir(ppy)3은 0.01 nm/s였다. LiF는 0.01 nm/s의 속도로 1 nm의 두께로 형성하였고, Al은 0.5nm/sec의 증착속도로 100 nm의 두께로 형성하였다. 소자 형성후 CaO 흡습제와 유리 커버 글라스를 이용하여 소자를 밀봉하였다.Fabrication of the device was performed in the following manner. The ITO substrate was washed with pure water and isopropyl alcohol for 30 minutes in ultrasonic waves, and the surface of the ITO substrate was treated with short wavelength ultraviolet rays, and the organic material was vacuum deposited under a pressure of 1 × 10 −6 torr. DNTPD, Compound 1, and Alq 3 were deposited at a rate of 0.1 nm / s to form films corresponding to each thickness. PH1 was vacuum deposited with an Ir (ppy) 3 dopant, where the deposition rate was 0.1 nm / s, Ir (ppy) 3 was 0.01 nm / s. LiF was formed at a thickness of 1 nm at a rate of 0.01 nm / s, and Al was formed at a thickness of 100 nm at a deposition rate of 0.5 nm / sec. After the device was formed, the device was sealed using a CaO absorbent and a glass cover glass.

실시예2Example 2

본 발명에서 합성한 화합물 6을 녹색인광 소자의 정공수송층의 물질로서 적용하여 녹색인광소자를 제작하였다.Compound 6 synthesized in the present invention was applied as a material of the hole transport layer of the green phosphor to prepare a green phosphor.

소자의 구조는 ITO/DNTPD(N,N'-diphenyl-N.N'-bis-[4-(phenyl-m-tolyl-amino)-phenyl]-biphenyl-4,4'-diamine, 60nm)/화합물 6(30nm)/PH1:Ir(ppy)3(30nm, 10%)/Alq3(20nm)/LiF/Al 이었다.The structure of the device is ITO / DNTPD (N, N'-diphenyl-N.N'-bis- [4- (phenyl-m-tolyl-amino) -phenyl] -biphenyl-4,4'-diamine, 60nm) / Compound 6 (30 nm) / PH1: Ir (ppy) 3 (30 nm, 10%) / Alq 3 (20 nm) / LiF / Al.

소자의 제작은 다음과 같은 방법으로 수행하였다. ITO 기판은 순수와 이소프로필 알코올을 이용하여 초음파에서 30분간 세정한 후 ITO 기판을 단파장의 자외선을 이용하여 표면처리한 후 1x10-6 torr의 압력하에서 유기물을 진공 증착하였다. DNTPD, 화합물 6, Alq3은 0.1 nm/s의 속도로 증착하여 각 두께에 해당하는 막을 형성하였고, PH1은 Ir(ppy)3 도펀트와 진공증착하였으며, 이 때 증착속도는 PH1은 0.1 nm/s, Ir(ppy)3은 0.01 nm/s였다. LiF는 0.01nm/s의 속도로 1 nm의 두께로 형성하였고, Al은 0.5 nm/sec의 증착속도로 100nm의 두께로 형성하였다. 소자 형성 후 CaO 흡습제와 유리 커버 글라스를 이용하여 소자를 밀봉하였다. Fabrication of the device was performed in the following manner. The ITO substrate was washed with pure water and isopropyl alcohol for 30 minutes in ultrasonic waves, and the surface of the ITO substrate was treated with short wavelength ultraviolet rays, and the organic material was vacuum deposited under a pressure of 1 × 10 −6 torr. DNTPD, Compound 6, and Alq 3 were deposited at a rate of 0.1 nm / s to form films corresponding to each thickness, and PH1 was vacuum-deposited with Ir (ppy) 3 dopant. At this time, the deposition rate was 0.1 nm / s. , Ir (ppy) 3 was 0.01 nm / s. LiF was formed at a thickness of 1 nm at a rate of 0.01 nm / s, and Al was formed at a thickness of 100 nm at a deposition rate of 0.5 nm / sec. After the device was formed, the device was sealed using a CaO absorbent and a glass cover glass.

실시예 1 내지 4 및 비교예 1, 2의 양자효율은 Forrest 논문(G. Gu and S. R. Forrest, IEEE Journal of Selected Topics in Quantum Electronics, Vol. 4, No. 1, January / February 1998, p. 83 - 99)에 기재된 바에 따라 측정하였다.The quantum efficiencies of Examples 1 to 4 and Comparative Examples 1 and 2 are described in G. Gu and SR Forrest, IEEE Journal of Selected Topics in Quantum Electronics, Vol. 4, No. 1, January / February 1998, p. 83 -99).

도 2를 참조하면 본 발명에서 제작한 녹색 인광소자는 최대 양자 효율 17.8 %를 보였다. Referring to FIG. 2, the green phosphor manufactured in the present invention showed a maximum quantum efficiency of 17.8%.

실시예Example 3 3

본 발명에서 합성한 화합물 2를 녹색인광 소자의 전자수송층 재료로서 적용하여 녹색인광소자를 제작하였다.Compound 2 synthesized in the present invention was applied as an electron transport layer material of the green phosphor to prepare a green phosphor.

소자의 구조는 ITO/DNTPD(60nm)/N,N'-di(1-naphthyl)-N,N'-diphenylbenzidine (NPB, 30 nm)/(4,4'-N,N'-dicarbazole)biphenyl(CBP):Ir(ppy)3(30nm, 10%)/화합물2(20nm)/LiF/Al 이었다.The structure of the device is ITO / DNTPD (60nm) / N, N'-di (1-naphthyl) -N, N'-diphenylbenzidine (NPB, 30 nm) / (4,4'-N, N'-dicarbazole) biphenyl (CBP): Ir (ppy) 3 (30 nm, 10%) / Compound 2 (20 nm) / LiF / Al.

소자의 제작은 다음과 같은 방법으로 수행하였다. ITO 기판은 순수와 이소프로필 알코올을 이용하여 초음파에서 30분간 세정한 후 ITO 기판을 단파장의 자외선을 이용하여 표면처리한 후 1x10-6 torr의 압력하에서 유기물을 진공 증착하였다. DNTPD, 화합물 2, NPB는 0.1 nm/s의 속도로 증착하여 각 두께에 해당하는 막을 형성하였고, CBP는 Ir(ppy)3 도펀트와 진공증착하였으며, 이 때 증착속도는 CBP은 0.1 nm/s, Ir(ppy)3은 0.01 nm/s였다. LiF는 0.01nm/s의 속도로 1 nm의 두께로 형성하였고, Al은 0.5 nm/sec의 증착속도로 100nm의 두께로 형성하였다. 소자 형성 후 CaO 흡습제와 유리 커버 글라스를 이용하여 소자를 밀봉하였다.Fabrication of the device was performed in the following manner. The ITO substrate was washed with pure water and isopropyl alcohol for 30 minutes in ultrasonic waves, and the surface of the ITO substrate was treated with short wavelength ultraviolet rays, and the organic material was vacuum deposited under a pressure of 1 × 10 −6 torr. DNTPD, Compound 2, and NPB were deposited at a rate of 0.1 nm / s to form films corresponding to each thickness. CBP was vacuum deposited with Ir (ppy) 3 dopant, and the deposition rate was 0.1 nm / s for CBP. Ir (ppy) 3 was 0.01 nm / s. LiF was formed at a thickness of 1 nm at a rate of 0.01 nm / s, and Al was formed at a thickness of 100 nm at a deposition rate of 0.5 nm / sec. After the device was formed, the device was sealed using a CaO absorbent and a glass cover glass.

제작한 소자는 양자효율 10.5%를 나타내었다.The fabricated device had a quantum efficiency of 10.5%.

실시예 4Example 4

본 발명에서 합성한 화합물 2를 녹색인광 소자의 호스트 재료로서 적용하여 녹색인광소자를 제작하였다.Compound 2 synthesized in the present invention was applied as a host material of the green phosphor to prepare a green phosphor.

소자의 구조는 ITO/DNTPD(60nm)/NPB(30nm)/화합물2:Ir(ppy)3(30nm, 10%)/Alq3(20nm)/LiF/Al 이었다.The structure of the device was ITO / DNTPD (60 nm) / NPB (30 nm) / Compound 2: Ir (ppy) 3 (30 nm, 10%) / Alq 3 (20 nm) / LiF / Al.

소자의 제작은 다음과 같은 방법으로 수행하였다. ITO 기판은 순수와 이소프로필 알코올을 이용하여 초음파에서 30분간 세정한 후 ITO 기판을 단파장의 자외선을 이용하여 표면처리한 후 1x10-6 torr의 압력하에서 유기물을 진공 증착하였다. DNTPD, NPB, Alq3은 0.1 nm/s의 속도로 증착하여 각 두께에 해당하는 막을 형성하였고, 화합물 2는 Ir(ppy)3 도펀트와 진공증착하였으며, 이 때 증착속도는 화합물 2는 0.1 nm/s, Ir(ppy)3은 0.01 nm/s였다. LiF는 0.01nm/s의 속도로 1 nm의 두께로 형성하였고, Al은 0.5 nm/sec의 증착속도로 100nm의 두께로 형성하였다. 소자 형성 후 CaO 흡습제와 유리 커버 글라스를 이용하여 소자를 밀봉하였다.Fabrication of the device was performed in the following manner. The ITO substrate was washed with pure water and isopropyl alcohol for 30 minutes in ultrasonic waves, and the surface of the ITO substrate was treated with short wavelength ultraviolet rays, and the organic material was vacuum deposited under a pressure of 1 × 10 −6 torr. DNTPD, NPB, and Alq 3 were deposited at a rate of 0.1 nm / s to form films corresponding to each thickness. Compound 2 was vacuum deposited with Ir (ppy) 3 dopant, and the deposition rate was 0.1 nm / s. s and Ir (ppy) 3 were 0.01 nm / s. LiF was formed at a thickness of 1 nm at a rate of 0.01 nm / s, and Al was formed at a thickness of 100 nm at a deposition rate of 0.5 nm / sec. After the device was formed, the device was sealed using a CaO absorbent and a glass cover glass.

제작한 소자는 양자효율 10.5%를 나타내었다. The fabricated device had a quantum efficiency of 10.5%.

비교예 1Comparative Example 1

비교예로서 일반적으로 정공수송층 물질로 많이 적용되는 NPB를 이용하여 소자를 제작하였다. 소자 구조는 ITO/DNTPD(60nm)/NPB(30nm)/PH1:Ir(ppy)3(30nm, 10%)/Alq3(20nm)/LiF/Al이었다.As a comparative example, devices were fabricated using NPB, which is generally applied as a hole transport layer material. The device structure was ITO / DNTPD (60 nm) / NPB (30 nm) / PH1: Ir (ppy) 3 (30 nm, 10%) / Alq 3 (20 nm) / LiF / Al.

소자의 제작은 정공수송물질로서 화합물 1을 사용하지 않고 대신에 NPB를 사용한 것을 제외하고는 실시예 1과 같은 방법으로 수행하였다.The device was fabricated in the same manner as in Example 1, except that Compound 1 was not used as the hole transport material and NPB was used instead.

도 2를 참고하면 본 구조의 녹색 인광 소자는 양자 효율 6.7 %로 낮은 양자 효율을 나타내었다. Referring to FIG. 2, the green phosphorescent device of the present structure exhibited low quantum efficiency of 6.7%.

양자효율 비교 데이터를 표 2에 나타내었다. Quantum efficiency comparison data is shown in Table 2.

양자효율(%)Quantum Efficiency (%) 색좌표Color coordinates 실시예 1Example 1 16.516.5 (0.31, 0.62)(0.31, 0.62) 실시예 2Example 2 11.511.5 (0.32, 0.62)(0.32, 0.62) 실시예 3Example 3 10.910.9 (0.28, 0.63)(0.28, 0.63) 실시예 4Example 4 9.19.1 (0.28, 0.60)(0.28, 0.60) 비교예 1Comparative Example 1 6.36.3 (0.31, 0.59)(0.31, 0.59)

Claims (15)

하기 화학식 1로 표시되는 스파이로 화합물.
[화학식 1]
Figure pat00273

상기 화학식 1에서,
R1 내지 R6은 서로 동일하거나 다르고, 모두 수소원자일 수 없으며,
R1 내지 R6 중 적어도 하나는 각각 독립적으로
Figure pat00274
,
Figure pat00275
,
Figure pat00276
, 또는
Figure pat00277
이고, 상기 R1 내지 R6 중 나머지는 각각 독립적으로 수소원자, C1 -9의 알킬기, C6 -30의 아릴기 또는 C5 -30의 헤테로 아릴기이며,
또한 R1 내지 R6 중 적어도 하나는 각각 독립적으로 이웃한 벤젠고리의 탄소원자와 결합하여 함께 접합된 방향족 고리 또는 접합된 헤테로 방향족 고리를 형성할 수 있으며,
상기 R7 내지 R9는 각각 독립적으로 수소원자 또는 C1 -9의 알킬기이며,
상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자, C6 -30의 아릴기 또는 C5 -30의 헤테로아릴기이다.
A spiro compound represented by the following formula (1).
[Formula 1]
Figure pat00273

In Chemical Formula 1,
R 1 to R 6 are the same as or different from each other, and all may not be a hydrogen atom,
R 1 to R 6 At least one of each independently
Figure pat00274
,
Figure pat00275
,
Figure pat00276
, or
Figure pat00277
And R 1 to R 6 The remaining are each independently a hydrogen atom, a heteroaryl group of the alkyl group of C 1 -9, C 6 -30 aryl group or a C 5 -30,
And R 1 to R 6 At least one of each independently may combine with a carbon atom of a neighboring benzene ring to form a conjugated aromatic ring or a conjugated heteroaromatic ring,
The alkyl groups of the R 7 to R 9 is a hydrogen atom or a C 1-9, each independently,
Wherein Ar 1 to Ar 4 is a heteroaryl group are each independently a hydrogen atom, C 6 -30 aryl group or a C 5 -30.
제1항에 있어서, 상기 R1 내지 R6 중 적어도 하나는
Figure pat00278
인 것을 특징으로 하는 스파이로 화합물.
According to claim 1, wherein R 1 to R 6 At least one of
Figure pat00278
Spyro compound, characterized in that.
제1항에 있어서, 상기 R1 내지 R6 중 적어도 하나는
Figure pat00279
인 것을 특징으로 하는 스파이로 화합물.
According to claim 1, wherein R 1 to R 6 At least one of
Figure pat00279
Spyro compound, characterized in that.
제1항에 있어서, 상기 R1 내지 R6 중 적어도 하나는
Figure pat00280
인 것을 특징으로 하는 스파이로 화합물.
According to claim 1, wherein R 1 to R 6 At least one of
Figure pat00280
Spyro compound, characterized in that.
제1항에 있어서, 상기 R1 내지 R6 중 적어도 하나는
Figure pat00281
인 것을 특징으로 하는 스파이로 화합물.
According to claim 1, wherein R 1 to R 6 At least one of
Figure pat00281
Spyro compound, characterized in that.
제1항에 있어서, 상기 R1 내지 R6 중 나머지는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기이며, 상기 Ar1 내지 Ar4는 각각 독립적으로 수소원자 또는 C6 -30의 아릴기인 것을 특징으로 하는 스파이로 화합물.According to claim 1, wherein R 1 to R 6 Are each independently of the other an aryl group, a hydrogen atom or a C 6 -30, wherein Ar 1 to Ar 4 is selected from the compounds as a spy, it characterized in that each independently represents a hydrogen atom or an aryl group of C 6 -30. 제6항에 있어서, 상기 R1 내지 R6 중 나머지는 수소원자이며, 상기 Ar1 내지 Ar4는 수소원자인 것을 특징으로 하는 스파이로 화합물.According to claim 6, wherein R 1 to R 6 The rest of the hydrogen atoms, Ar 1 to Ar 4 is a spiro compound, characterized in that a hydrogen atom. 제1전극; 제2전극; 발광층; 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서,
상기 정공수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.
A first electrode; A second electrode; Light emitting layer; And a hole transport layer, wherein the light emitting layer includes a host and a dopant.
The hole transport layer is an organic light emitting device, characterized in that it comprises a spiro compound of claim 1.
제8항에 있어서, 상기 호스트는 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.The organic light emitting device of claim 8, wherein the host comprises a spiro compound of claim 1. 제8항에 있어서, 상기 유기전계 발광소자는 전자수송층을 추가로 포함하는 것을 특징으로 하는 유기전계 발광소자.The organic light emitting device of claim 8, wherein the organic light emitting device further comprises an electron transport layer. 제10항에 있어서, 상기 전자수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.The organic light emitting device of claim 10, wherein the electron transport layer comprises a spiro compound of claim 1. 제1전극; 제2전극; 발광층; 전자수송층 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서,
상기 호스트는 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.
A first electrode; A second electrode; Light emitting layer; In the organic light emitting device comprising an electron transport layer and a hole transport layer, the light emitting layer comprises a host and a dopant,
The host is an organic light emitting device, characterized in that it comprises a spiro compound of claim 1.
제12항에 있어서, 상기 전자수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.The organic light emitting device of claim 12, wherein the electron transport layer comprises a spiro compound of claim 1. 제12항에 있어서, 상기 유기전계 발광소자는 정공주입층 및 전자주입층 중 하나 이상의 층을 추가로 포함하는 것을 특징으로 하는 유기전계 발광소자.The organic light emitting device of claim 12, wherein the organic light emitting device further comprises at least one of a hole injection layer and an electron injection layer. 제1전극; 제2전극; 발광층; 전자수송층 및 정공수송층을 포함하고, 상기 발광층은 호스트와 도펀트를 포함하는 유기전계 발광소자에 있어서,
상기 전자수송층은 제1항의 스파이로 화합물을 포함하는 것을 특징으로 하는 유기전계 발광소자.
A first electrode; A second electrode; Light emitting layer; In the organic light emitting device comprising an electron transport layer and a hole transport layer, the light emitting layer comprises a host and a dopant,
The electron transport layer is an organic electroluminescent device, characterized in that it comprises a spiro compound of claim 1.
KR1020100113475A 2010-11-15 2010-11-15 Spiro Compound and Organic Light Emitting Device Including the Same KR101171232B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100113475A KR101171232B1 (en) 2010-11-15 2010-11-15 Spiro Compound and Organic Light Emitting Device Including the Same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100113475A KR101171232B1 (en) 2010-11-15 2010-11-15 Spiro Compound and Organic Light Emitting Device Including the Same

Publications (2)

Publication Number Publication Date
KR20120052034A true KR20120052034A (en) 2012-05-23
KR101171232B1 KR101171232B1 (en) 2012-08-06

Family

ID=46268876

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100113475A KR101171232B1 (en) 2010-11-15 2010-11-15 Spiro Compound and Organic Light Emitting Device Including the Same

Country Status (1)

Country Link
KR (1) KR101171232B1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
CN105349134A (en) * 2015-09-18 2016-02-24 中节能万润股份有限公司 Organic electroluminescent material and application thereof
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9533954B2 (en) 2010-12-22 2017-01-03 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9533984B2 (en) 2013-04-19 2017-01-03 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9611267B2 (en) 2012-06-13 2017-04-04 Incyte Holdings Corporation Substituted tricyclic compounds as FGFR inhibitors
KR20170041159A (en) * 2015-10-06 2017-04-14 주식회사 엘지화학 Aromatic compound and organic light emitting device comprising the same
US9708318B2 (en) 2015-02-20 2017-07-18 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9890156B2 (en) 2015-02-20 2018-02-13 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3305764A4 (en) * 2015-06-05 2018-12-26 LG Chem, Ltd. Double spiro organic compound and organic electronic element comprising same
KR20190098438A (en) * 2018-02-14 2019-08-22 주식회사 엘지화학 Amine derivative and organic light emitting device comprising the same
KR20190099849A (en) * 2018-02-20 2019-08-28 주식회사 엘지화학 Amine induced compound and organic light emitting device comprising the same
KR20190113311A (en) * 2018-03-28 2019-10-08 주식회사 엘지화학 Amine derivative and organic light emitting device comprising the same
US10611762B2 (en) 2017-05-26 2020-04-07 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11174257B2 (en) 2018-05-04 2021-11-16 Incyte Corporation Salts of an FGFR inhibitor
US11407750B2 (en) 2019-12-04 2022-08-09 Incyte Corporation Derivatives of an FGFR inhibitor
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11897891B2 (en) 2019-12-04 2024-02-13 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12065494B2 (en) 2021-04-12 2024-08-20 Incyte Corporation Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813930B2 (en) 2010-12-22 2020-10-27 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9533954B2 (en) 2010-12-22 2017-01-03 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US10213427B2 (en) 2010-12-22 2019-02-26 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US11840534B2 (en) 2012-06-13 2023-12-12 Incyte Corporation Substituted tricyclic compounds as FGFR inhibitors
US10131667B2 (en) 2012-06-13 2018-11-20 Incyte Corporation Substituted tricyclic compounds as FGFR inhibitors
US9611267B2 (en) 2012-06-13 2017-04-04 Incyte Holdings Corporation Substituted tricyclic compounds as FGFR inhibitors
US11053246B2 (en) 2012-06-13 2021-07-06 Incyte Corporation Substituted tricyclic compounds as FGFR inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9745311B2 (en) 2012-08-10 2017-08-29 Incyte Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
US9533984B2 (en) 2013-04-19 2017-01-03 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US10947230B2 (en) 2013-04-19 2021-03-16 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US10040790B2 (en) 2013-04-19 2018-08-07 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US11530214B2 (en) 2013-04-19 2022-12-20 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US10450313B2 (en) 2013-04-19 2019-10-22 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10738048B2 (en) 2015-02-20 2020-08-11 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11173162B2 (en) 2015-02-20 2021-11-16 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10251892B2 (en) 2015-02-20 2019-04-09 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11667635B2 (en) 2015-02-20 2023-06-06 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10214528B2 (en) 2015-02-20 2019-02-26 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11014923B2 (en) 2015-02-20 2021-05-25 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9708318B2 (en) 2015-02-20 2017-07-18 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10632126B2 (en) 2015-02-20 2020-04-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10016438B2 (en) 2015-02-20 2018-07-10 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9890156B2 (en) 2015-02-20 2018-02-13 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9801889B2 (en) 2015-02-20 2017-10-31 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11001752B2 (en) 2015-06-05 2021-05-11 Lg Chem, Ltd. Double spiro organic compound and organic electronic element comprising same
EP3305764A4 (en) * 2015-06-05 2018-12-26 LG Chem, Ltd. Double spiro organic compound and organic electronic element comprising same
CN105349134A (en) * 2015-09-18 2016-02-24 中节能万润股份有限公司 Organic electroluminescent material and application thereof
KR20170041159A (en) * 2015-10-06 2017-04-14 주식회사 엘지화학 Aromatic compound and organic light emitting device comprising the same
US11472801B2 (en) 2017-05-26 2022-10-18 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
US10611762B2 (en) 2017-05-26 2020-04-07 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
KR20190098438A (en) * 2018-02-14 2019-08-22 주식회사 엘지화학 Amine derivative and organic light emitting device comprising the same
KR20190099849A (en) * 2018-02-20 2019-08-28 주식회사 엘지화학 Amine induced compound and organic light emitting device comprising the same
KR20190113311A (en) * 2018-03-28 2019-10-08 주식회사 엘지화학 Amine derivative and organic light emitting device comprising the same
US11174257B2 (en) 2018-05-04 2021-11-16 Incyte Corporation Salts of an FGFR inhibitor
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
US12024517B2 (en) 2018-05-04 2024-07-02 Incyte Corporation Salts of an FGFR inhibitor
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12083124B2 (en) 2019-10-14 2024-09-10 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11897891B2 (en) 2019-12-04 2024-02-13 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
US11407750B2 (en) 2019-12-04 2022-08-09 Incyte Corporation Derivatives of an FGFR inhibitor
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12065494B2 (en) 2021-04-12 2024-08-20 Incyte Corporation Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors

Also Published As

Publication number Publication date
KR101171232B1 (en) 2012-08-06

Similar Documents

Publication Publication Date Title
KR101171232B1 (en) Spiro Compound and Organic Light Emitting Device Including the Same
JP5473600B2 (en) Chrysene derivative and organic electroluminescence device using the same
KR101092170B1 (en) Carbazole Type Phosphine Oxide Compound and Organic Light Emitting Device Including the Same
EP2085382B1 (en) Aromatic amine derivative and organic electroluminescent element using the same
KR101158144B1 (en) Material for organic electroluminescent device and organic electroluminescent device using same
EP2085371A1 (en) Fluoranthene compound, organic electroluminescent device using the fluoranthene compound, and organic electroluminescent material-containing solution
KR101467615B1 (en) Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same
KR101382373B1 (en) Cyclopentafluorene compound and organic light emitting device including the same
KR20100090280A (en) Benzophenanthrene derivative and organic electroluminescent device employing the same
KR20110000006A (en) Amine type spiro compound and organic light emitting device including the same
KR20100090269A (en) Fused aromatic derivative and organic electroluminescent device using the same
KR20110097784A (en) Aromatic amine derivative, and organic electroluminescent element
KR20100088612A (en) Benzochrysene derivative and organic electroluminescent device using the same
WO2010098458A1 (en) Organic electroluminescent element
KR20140001568A (en) Biscarbazole derivative for organic electroluminescent device and organic electroluminescent device including the same
KR20100088613A (en) Benzochrysene derivative and organic electroluminescent device using the same
WO2009081774A1 (en) Benzanthracene compound and organic electroluminescent device using the same
KR101472295B1 (en) Multicyclic aromatic compound and organic light emitting device including the same
KR20110117073A (en) Organic electroluminescent element material and organic electroluminescent element comprising same
KR101554680B1 (en) Aromatic amine compound and organic electroluminescent device including the same
KR20130134451A (en) Novel bicarbazole derivative for organic electroluminescent device and organic electroluminescent device including the same
WO2004110968A1 (en) Compound having spiro bond, material for luminescent coating formation and organic electroluminescence element including the same
KR20130134426A (en) Novel asymetric compound for organic electroluminescent device and organic electroluminescent device including the same
KR101027582B1 (en) Phosphine Oxide type Compound and Organic Light Emitting Device including the same
KR101072214B1 (en) White Organic Light Emitting Device

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150522

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160704

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170727

Year of fee payment: 6